Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction
Open accessAbstract
Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction. Fetal growth restriction is associated with perinatal morbidity and mortality.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
60 of 155 cited sources checked · 24 supported · 2 flagged · accuracy not yet measured
- Premisecitation
The finding of low-dose aspirin benefit was not confirmed in the ASPRE trial, which was primarily designed for preterm preeclampsia prevention.
“However, this finding was not confirmed in the Aspirin for Evidence-Based Preeclampsia Prevention (ASPRE) trial, which was primarily designed for preterm preeclampsia prevention.74,75”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [74] Rolnik, 2017, Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia, N Engl J Med source
The Primary Outcome section reports significantly less preterm preeclampsia with aspirin than placebo (1.6% versus 4.3%; P = 0.004), contrary to the claim that the trial did not confirm an aspirin benefit. The Discussion confirms that preterm preeclampsia was the trial’s primary outcome; it notes no significant differences for other outcomes, but says the trial was not adequately powered for them. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured - cites [75] Groom, 2018, The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction, Am J Obstet Gynecol source
- Interpretationcitation
The available evidence does not indicate improved accuracy of CPR over umbilical artery Doppler.
“The available evidence does not indicate improved accuracy of CPR over umbilical artery Doppler, and clinical trials are needed to evaluate the effectiveness of CPR in guiding clinical management, especially in late-onset FGR, before its use in routine surveillance of pregnancies with FGR can be recommended.139”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [139] Vollgraff Heidweiller-Schreurs, 2018, Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis, Ultrasound Obstet Gynecol source
The Results (Direct comparisons) and Discussion (Summary of main results) report that CPR was significantly more accurate than umbilical artery Doppler for composite adverse outcome and emergency delivery for fetal distress, though accuracy was similar for other outcomes. The Conclusion also says CPR can improve accuracy. The paper does call for clinical trials before using CPR to guide management, but that does not support the claim that the available evidence indicates no accuracy improvement. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measured
- Premisecitation
Fetal growth restriction can contribute to cardiac remodeling, leading to cardiovascular dysfunction that can persist into childhood and adolescence.
“It also can contribute to cardiac remodeling, leading to cardiovascular dysfunction that can persist into childhood and adolescence.13,14”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [13] Cruz-Lemini, 2016, Fetal cardiovascular remodeling persists at 6 months in infants with intrauterine growth restriction, Ultrasound Obstet Gynecol source
The Introduction and Discussion report that intrauterine growth restriction is associated with fetal cardiovascular remodeling and dysfunction, and the study found that the pattern persisted at six months. The Introduction also discusses cardiovascular changes in children and young adults, but the Strengths and limitations section says persistence of this study’s findings in the long term remains to be established. It therefore does not establish that the cardiac dysfunction persists into adolescence. (LLM, conf=0.86)
Experimental — accuracy not yet measured - cites [14] Crispi, 2010, Fetal growth restriction results in remodeled and less efficient hearts in children, Circulation source
- Premisecitation
Perinatal outcomes in fetal growth restriction are largely dependent on severity, with the worst outcomes in fetuses with estimated fetal weight less than the third percentile or fetal Doppler abnormalities.
“Perinatal outcomes are largely dependent on the severity of FGR, with the worst outcomes noted in fetuses with estimated fetal weights (EFWs) at less than the third percentile or in association with fetal Doppler abnormalities.5,10”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [5] Unterscheider, 2014, Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study, BMC Pregnancy Childbirth source
- cites [10] Savchev, 2012, Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices, Ultrasound Obstet Gynecol source
- Premisecitation
Fetal growth restriction can result from a variety of maternal, fetal, and placental conditions.
“Fetal growth restriction (FGR) can result from a variety of maternal, fetal, and placental conditions. 1”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [1] Swanson, 2015, Animal models of fetal growth restriction: Considerations for translational medicine, Placenta source
- Premisecitation
Fetal growth restriction is associated with metabolic programming that increases the risk of future development of metabolic syndrome and consequent cardiovascular and endocrine diseases.
“It has been associated with metabolic programming that increases the risk of future development of metabolic syndrome and consequent cardiovascular and endocrine diseases.11,12”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [11] Crispi, 2012, Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity, Am J Obstet Gynecol source
- cites [12] Crispi, 2018, Long-term cardiovascular consequences of fetal growth restriction: biology, clinical implications, and opportunities for prevention of adult disease, Am J Obstet Gynecol source
The Abstract states that fetal growth restriction causes metabolic programming that may increase the risk of metabolic syndrome and, consequently, adult cardiovascular morbidity. The Fetal Programming of Adult Cardiovascular Disease section also discusses diabetes as a metabolic disease, but does not say that metabolic syndrome leads to endocrine diseases. The claim therefore adds an unsupported consequence and is more certain than the paper’s qualified statement. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
Prospective studies fail to demonstrate the superiority of the fetal growth trajectory approach in improving clinical outcomes.
“However, this approach requires multiple ultrasound examinations, and prospective studies fail to demonstrate the superiority of this approach in improving clinical outcomes.35”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [35] Grantz, 2018, Fetal growth standards: the NICHD fetal growth study approach in context with INTERGROWTH-21st and the World Health Organization Multicentre Growth Reference Study, Am J Obstet Gynecol source
The Conclusion (page unavailable) says that estimating a fetal growth trajectory requires at least two measurements and that one-time measurement remains standard clinical practice. It does not report that prospective studies tested the trajectory approach against another approach or failed to show superior clinical outcomes. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Premisecitation
The primary underlying mechanisms for fetal growth restriction are varied but often share a final common pathway of suboptimal fetal nutrition and uteroplacental perfusion.
“Although the primary underlying mechanisms for FGR are varied, they often share the same final common pathway of suboptimal fetal nutrition and uteroplacental perfusion.1,2”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [1] Swanson, 2015, Animal models of fetal growth restriction: Considerations for translational medicine, Placenta source
- cites [2] Bamfo, 2011, Diagnosis and management of fetal growth restriction, J Pregnancy source
Section 2.1 (Causes) describes varied fetal, maternal, environmental, and placental causes of FGR and says uteroplacental hypoperfusion can impair fetal growth. Section 2.2 (Placental Dysfunction) links inadequate placentation to FGR and describes the placenta’s role in nutrient absorption. The paper does not establish that these varied causes often converge on a shared final pathway involving both suboptimal fetal nutrition and uteroplacental perfusion. (LLM, conf=0.78)
Experimental — accuracy not yet measured
- Premisecitation
Of fetuses diagnosed with fetal growth restriction, approximately 18%-22% will be constitutionally small but healthy at birth with a normal outcome.
“Of fetuses diagnosed with FGR, approximately 18%e22% will be constitutionally small but healthy at birth with a normal outcome.24”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] McCowan, 2018, Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy, Am J Obstet Gynecol source
The Introduction says 18–22% of babies classified as small for gestational age (SGA) are constitutionally small but healthy. The Expert Reviews section says reclassified babies have perinatal mortality similar to normally grown babies. The figure applies to SGA infants, not fetuses diagnosed with FGR, and similar mortality does not establish a normal outcome in every respect. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
A review of national guidelines from 6 countries reveals broad consensus that fetal growth restriction is defined as an ultrasonographic estimated fetal weight below the 10th percentile for gestational age.
“A review of national guidelines for the diagnostic criteria for FGR from 6 countries (United States, United Kingdom, France, Ireland, Canada, and New Zealand) reveals a broad consensus on this definition of FGR.24”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [24] McCowan, 2018, Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy, Am J Obstet Gynecol source
- Premisecitation
The single most important prognostic factor in preterm fetuses with growth restriction is the gestational age at delivery.
“The single most important prognostic factor in preterm fetuses with growth restriction is the gestational age at delivery.80,83”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
The Results (page not available) say gestational age at delivery was strongly related to infant outcome, and babies with poor outcomes were delivered earlier. They do not identify it as the single most important prognostic factor; the Discussion instead calls maternal hypertension the major determinant of adverse outcome. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [83] Baschat, 2007, Predictors of neonatal outcome in early-onset placental dysfunction, Obstet Gynecol source
The Results report that gestational age was the most significant determinant of neonatal survival until 26 6/7 weeks. The claim is broader than that finding: the paper describes gestational age as a significant contributor to major morbidity until 29 2/7 weeks, and the Discussion identifies ductus venosus abnormality as an important predictor of neonatal complications beyond 27 weeks. Page numbers were not provided in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Premisecitation
The presence of maternal hypertension was one of the most important independent determinants of poor outcomes.
“The presence of maternal hypertension was one of the most important independent determinants of poor outcomes.16,80”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [16] Lees, 2015, 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial, Lancet source
- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
- Premisecitation
Up to 20% of early-onset fetal growth restriction cases are associated with fetal or chromosomal abnormalities.
“We recommend that a detailed obstetrical ultrasound examination (current procedural terminology code 76811) be performed with early-onset FGR because up to 20% of cases are associated with fetal or chromosomal abnormalities 2,3,84,85 (GRADE 1B).”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [2] Bamfo, 2011, Diagnosis and management of fetal growth restriction, J Pregnancy source
Section 2.1 (Causes; page not provided) identifies fetal malformations and aneuploidy as causes of FGR. It does not give an up-to-20% figure for fetal or chromosomal abnormalities in early-onset FGR. Its separate figure of over 20% concerns confined placental mosaicism in idiopathic FGR. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [3] Resnik, 2002, Intrauterine growth restriction, Obstet Gynecol source
- cites [84] Hendrix, 2008, Non-placental causes of intrauterine growth restriction, Semin Perinatol source
- cites [85] Maulik, 2006, Fetal growth restriction: the etiology, Clin Obstet Gynecol source
- Premisecitation
In early-onset fetal growth restriction, the pattern of Doppler deterioration progresses from abnormalities in the umbilical arteries and the ductus venosus to abnormal biophysical parameters.
“In early-onset FGR, the pattern of Doppler deterioration progresses from abnormalities in the umbilical arteries and the ductus venosus to abnormal biophysical parameters.55,56”
Quote in the paperNot a substantial claim1 of 2 sources checked - Premisecitation
Low-molecular-weight heparin has not been shown to reduce the risk of recurrent placenta-mediated pregnancy complications in at-risk women.
“Furthermore, the use of low-molecularweight heparin has not been shown to reduce the risk of recurrent placenta-mediated pregnancy complications in at-risk women.75,77,78”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [75] Groom, 2018, The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction, Am J Obstet Gynecol source
- cites [77] Haddad, 2016, Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial, Obstet Gynecol source
- cites [78] Groom, 2017, Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial, Am J Obstet Gynecol source
- Premisecitation
The presence of a standardized protocol for diagnosis and management appears to be associated with more favorable outcomes, as evidenced in the TRUFFLE trial.
“Furthermore, the presence of a standardized protocol for diagnosis and management appears to be associated with more favorable outcomes, as evidenced in the better-than-expected perinatal morbidity and mortality in the Trial of Randomized Umbilical and Fetal Flow in Europe (TRUFFLE).80”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
- Premisecitation
A large longitudinal cohort study on fetal growth restriction showed an increase of 1%-2% in intact survival for every additional day spent in utero up until 32 weeks of gestation.
“A large longitudinal cohort study on FGR showed an increase of 1%e2% in intact survival for every additional day spent in utero up until 32 weeks of gestation.83”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [83] Baschat, 2007, Predictors of neonatal outcome in early-onset placental dysfunction, Obstet Gynecol source
The Results report that this large study of growth-restricted fetuses found neonatal survival gains of about 2% per day in utero from 24 to 27 weeks and 1% thereafter; they also report increasing intact survival through 32 weeks. The paper does not assign those per-day percentages to intact survival, as the citing sentence does. (LLM, conf=0.88)
Experimental — accuracy not yet measured
- Premisecitation
At present, there is no evidence that therapeutic interventions, including sildenafil, improve placental perfusion and outcome in pregnancies with fetal growth restriction.
“At present, there is no evidence that therapeutic interventions, including sildenafil to augment uteroplacental perfusion through vasodilation, improve placental perfusion and outcome in pregnancies with FGR.75,79”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [75] Groom, 2018, The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction, Am J Obstet Gynecol source
The Implications for practice section (page unavailable) says there are no proven treatments that improve fetal growth or outcome after FGR is diagnosed. But the clinical-studies discussion (page unavailable) reports reduced umbilical artery resistance after a single sildenafil dose in FGR pregnancies, evidence of an effect on fetoplacental circulation. Thus the claim captures the lack of a proven outcome benefit but overstates the absence of evidence for a perfusion-related effect. (LLM, conf=0.82)
Experimental — accuracy not yet measured - cites [79] Groom, 2019, STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction, Bjog source
- Premisecitation
In a secondary analysis of TRUFFLE data, middle cerebral artery Doppler did not add useful information beyond umbilical artery and ductus venosus Doppler assessments for optimizing timing of delivery.
“Similarly, in a secondary analysis of data from TRUFFLE, middle cerebral artery Doppler did not add useful information beyond umbilical artery and ductus venosus Doppler assessments for optimizing the timing of delivery.131”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [131] Stampalija, 2017, Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction?, Am J Obstet Gynecol source
The Abstract’s Study Design identifies this as a secondary analysis of TRUFFLE, and its Conclusion says middle cerebral artery Doppler is unlikely to help optimize delivery timing in fetal growth restriction before 32 weeks. However, the Conclusion describes a monitoring protocol based on ductus venosus Doppler and cardiotocography, not a comparison against combined umbilical artery and ductus venosus Doppler assessments. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
Evidence suggests that umbilical artery Doppler does not reliably predict adverse pregnancy outcome in late-onset FGR.
“Evidence suggests that umbilical artery Doppler does not reliably predict adverse pregnancy outcome in late-onset FGR.101”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [101] Oros, 2011, Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-for-gestational age fetuses, Ultrasound Obstet Gynecol source
- Interpretationcitation
The risks of stillbirth for AEDV and REDV are higher than the risk of infant mortality or severe morbidity at 33e34 weeks for AEDV and at 30e32 weeks for REDV as reported in TRUFFLE.
“These risks of stillbirth are higher than the risk of infant mortality or severe morbidity at 33e34 weeks for AEDV and at 30e32 weeks for REDV as reported in TRUFFLE.80”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
Table 4 (section labeled Discussion; page unavailable) reports neonatal death and severe morbidity by gestational age at delivery, providing TRUFFLE outcomes relevant to the comparison. But it does not separate AEDV from REDV or compare those groups’ stillbirth risks with infant outcomes at the stated weeks; that comparison is not established by this source. (LLM, conf=0.87)
Experimental — accuracy not yet measured
- Interpretationcitation
Umbilical artery Doppler is an essential component of fetal surveillance in FGR.
“As such, it is an essential component of fetal surveillance in FGR.96,97”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [96] McCowan, 2000, A pilot randomized controlled trial of two regimens of fetal surveillance for small-for-gestational-age fetuses with normal results of umbilical artery doppler velocimetry, Am J Obstet Gynecol source
- cites [97] Alfirevic, 2017, Fetal and umbilical Doppler ultrasound in high-risk pregnancies, Cochrane Database Syst Rev source
The Authors’ Conclusions (Implications for practice; page unavailable) say umbilical artery Doppler improves perinatal outcomes in high-risk pregnancies at risk of placental insufficiency and identify small-for-date fetuses as obvious candidates. That supports its use in fetal growth restriction, but the review does not establish that it is essential for surveillance in every FGR pregnancy. (LLM, conf=0.82)
Experimental — accuracy not yet measured
- Rests on an assumption: An abnormal umbilical artery Doppler waveform reflects the presence of placental insufficiency and can help differentiate the growth-restricted fetus from the constitutionally small fetus.
- Premisecitation
After 32 weeks of gestation, abnormal CTG findings will almost invariably precede Doppler abnormalities of the ductus venosus.
“After 32 weeks of gestation, abnormal CTG findings will almost invariably precede Doppler abnormalities of the ductus venosus.111”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [111] Baschat, 2003, Qualitative venous Doppler waveform analysis improves prediction of critical perinatal outcomes in premature growth-restricted fetuses, Ultrasound Obstet Gynecol source
The Discussion (page unavailable) describes cardiotocography as complementary to Doppler surveillance, but does not say which finding occurs first. A search for “32 weeks” found no gestational-age-specific comparison, so our copy does not verify the claimed sequence after 32 weeks. (LLM, conf=0.75)
Experimental — accuracy not yet measured
- Premisecitation
A systematic review of 5 trials found no evidence of maternal or neonatal benefit from routine umbilical artery Doppler in low-risk pregnancies.
“In contrast, a systematic review of 5 trials found no evidence of maternal or neonatal benefit from the routine use of umbilical artery Doppler in low-risk pregnancies.98”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [98] Alfirevic, 2015, Fetal and umbilical Doppler ultrasound in normal pregnancy, Cochrane Database Syst Rev source
- Premisecitation
A prospective observational study suggests that rapid progression of Doppler abnormalities in FGR, if it occurs, is typically noted within the first 2 weeks after diagnosis.
“A prospective observational study of the progression of Doppler abnormalities in FGR suggests that rapid progression, if it is going to occur, is typically noted within the first 2 weeks after diagnosis.24,108”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [24] McCowan, 2018, Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy, Am J Obstet Gynecol source
The Results discuss surveillance after FGR diagnosis, and the Conclusions table lists Doppler monitoring intervals. Neither reports a prospective observational study finding that rapid Doppler deterioration typically appears within the first two weeks after diagnosis. Searches for that study and the two-week progression claim found no supporting passage in our copy. (LLM, conf=0.73)
Experimental — accuracy not yet measured - cites [108] Turan, 2008, Progression of Doppler abnormalities in intrauterine growth restriction, Ultrasound Obstet Gynecol source
- Premisecitation
There are currently no randomized trials with adequate sample size to inform recommendations regarding the optimal frequency of umbilical artery Doppler for FGR surveillance.
“There are currently no randomized trials with adequate sample size to inform recommendations regarding the optimal frequency of umbilical artery Doppler for FGR surveillance.107”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [107] Grivell, 2012, Regimens of fetal surveillance for impaired fetal growth, Cochrane Database Syst Rev source
- Premisecitation
In TRUFFLE, delivery decisions guided by ductus venosus Doppler findings accounted for about 11% of pregnancies allocated to the late ductus venosus findings group because most delivered due to other fetal or maternal indications.
“In TRUFFLE, delivery decisions guided by ductus venosus Doppler findings only accounted for about 11% of pregnancies allocated to the late ductus venosus findings group because most delivered due to other fetal or maternal indications.115,120,121”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [115] Ganzevoort, 2017, How to monitor pregnancies complicated by fetal growth restriction and delivery before 32 weeks: post-hoc analysis of TRUFFLE study, Ultrasound Obstet Gynecol source
The Introduction says that only a proportion of fetuses allocated to delivery for ductus venosus changes were delivered on that criterion; the majority were delivered under safety-net criteria. It does not give the claimed 11% figure for the late ductus venosus group or specify that the other deliveries were due to fetal or maternal indications. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [120] Bilardo, 2017, Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study, Ultrasound Obstet Gynecol source
The section on deliveries for reasons other than abnormal DV Doppler (p. 4) says many women delivered for other reasons, including maternal complications and fetal distress. The section on neurological outcome (p. 4) also says that, across the two DV groups, twice as many fetuses delivered under CTG safety-net criteria as for DV changes. Neither passage gives 11% as the proportion of the late-DV group delivered because of DV findings; the reported 11% figures refer to other indications across the trial. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [121] Visser, 2017, Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study, Ultrasound Obstet Gynecol source
The Results report that 10% of cases in the late ductus venosus (DV-no-A) group were delivered for the allocated Doppler finding, consistent with 'about 11%.' But they say more than 50% were delivered because of safety-net criteria and almost 40% for other fetal or maternal indications. The claim incorrectly makes the latter the majority reason. (LLM, conf=0.92)
Experimental — accuracy not yet measured
- Premisecitation
Uterine artery Doppler has limited diagnostic accuracy and clinical utility in predicting FGR, SGA birth, and perinatal mortality.
“However, uterine artery Doppler has limited diagnostic accuracy and clinical utility in predicting FGR, SGA birth, and perinatal mortality.148,149”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [148] Chien, 2000, How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview, Bjog source
- cites [149] Parry, 2017, Role of early second-trimester uterine artery Doppler screening to predict small-for-gestational-age babies in nulliparous women, Am J Obstet Gynecol source
The Comment reports a systematic review finding limited diagnostic accuracy for fetal growth restriction and perinatal death. It also reports low predictive and clinical utility for SGA and stillbirth in this study’s cohort of unselected nulliparous women screened in the early second trimester. The claim omits that population and timing limitation and extends the clinical-utility finding to FGR and perinatal mortality, which this study did not directly assess as such. (LLM, conf=0.84)
Experimental — accuracy not yet measured
- Premisecitation
A normal CTG in pregnancies with FGR is more likely to be associated with a normal perinatal outcome.
“a normal CTG in pregnancies with FGR is more likely to be associated with a normal perinatal outcome”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [121] Visser, 2017, Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study, Ultrasound Obstet Gynecol source
The Results (page not available) report that 80% of infants delivered because of CTG abnormalities were normal at follow-up. Our copy does not compare outcomes after normal versus abnormal CTG, so it does not establish the claimed association; searches for normal CTG and outcomes found no such comparison. (LLM, conf=0.70)
Experimental — accuracy not yet measured
- Rests on an assumption: CTG is currently accepted as the primary method for fetal surveillance in high-risk pregnancies in the United States.
- Premisecitation
The presence of spontaneous repetitive late decelerations is accepted as an indication for delivery in viable pregnancies with FGR, irrespective of Doppler findings.
“the presence of spontaneous repetitive late decelerations is accepted as an indication for delivery in viable pregnancies with FGR, irrespective of Doppler findings”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [121] Visser, 2017, Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study, Ultrasound Obstet Gynecol source
The Methods describe recurrent fetal-heart-rate decelerations as a delivery safety-net criterion in all three monitoring groups, including the groups monitored by ductus venosus Doppler. The paper does not specify that these were *late* decelerations, and its study population was pregnancies with very preterm fetal growth restriction at 26–32 weeks, not viable FGR pregnancies generally. The cited copy provides no page number for the Methods passage. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Rests on an assumption: CTG is currently accepted as the primary method for fetal surveillance in high-risk pregnancies in the United States.
- Premisecitation
In early-onset FGR associated with abnormal Doppler studies, neonatal survival increased from 13% at 24 weeks to 43% at 25 weeks and 58%-76% at 26 weeks of gestation.
“In early-onset FGR associated with abnormal Doppler studies, neonatal survival increased from 13% at 24 weeks to 43% at 25 weeks and 58%-76% at 26 weeks of gestation.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [159] Visser, 2014, Fetal growth restriction at the limits of viability, Fetal Diagn Ther source
- Premisecitation
A Cochrane review concluded that available evidence from randomized controlled trials does not support the use of BPP as a test of fetal well-being in high-risk pregnancies.
“A Cochrane review concluded that available evidence from randomized controlled trials does not support the use of BPP as a test of fetal well-being in high-risk pregnancies.153,154”
Quote in the paperSubstantial claim2 of 2 sources checked- cites [153] Lalor, 2008, Biophysical profile for fetal assessment in high risk pregnancies, Cochrane Database Syst Rev source
- cites [154] Kaur, 2008, Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh <1000 g, Am J Obstet Gynecol source
The COMMENT and SMFM Papers sections conclude that BPP alone is unreliable for predicting fetal well-being in severely preterm, growth-restricted fetuses. The paper does not report a Cochrane review or a conclusion from randomized controlled trials, and its findings do not cover high-risk pregnancies generally. Page numbers are unavailable in our copy. (LLM, conf=0.85)
Experimental — accuracy not yet measured
- Rests on an assumption: More recent studies have questioned the value of BPP in fetal surveillance of high-risk pregnancies, including early-onset severe FGR, because of a high prevalence of false-positive and false-negative results.
- Premisecitation
National guidelines from 4 countries recommend cesarean delivery when FGR is complicated by AEDV/REDV of the umbilical artery.
“National guidelines from 4 countries recommend cesarean delivery when FGR is complicated by AEDV/REDV of the umbilical artery.24”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [24] McCowan, 2018, Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy, Am J Obstet Gynecol source
- Rests on an assumption: The decision for delivery in FGR is driven by fetal and maternal factors.
- Premisecitation
Observational studies have indicated that an abnormal biophysical profile is a late manifestation of placental disease that appears to become abnormal 48e72 hours after ductus venosus Doppler abnormalities in 90% of cases.
“Observational studies have indicated that an abnormal biophysical profile (BPP) is a late manifestation of placental disease that appears to become abnormal 48e72 hours after ductus venosus Doppler abnormalities in 90% of cases.152”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [152] Baschat, 2001, The sequence of changes in Doppler and biophysical parameters as severe fetal growth restriction worsens, Ultrasound Obstet Gynecol source
The Results (p. 4) and Discussion (p. 6) support that Doppler deterioration, including changes in the ductus venosus, generally precedes a late decline in biophysical profile score. They do not support the claimed 48–72-hour interval in 90% of cases: the Results report a median of four days between accelerating ductus venosus indices and score decline, while the Abstract (p. 1) says Doppler deterioration was complete 24 hours before decline in 70.5% of cases and was simultaneous in 25%. (LLM, conf=0.90)
Experimental — accuracy not yet measured
- Premisecitation
Evidence to date indicates that the use of new formulas in clinical practice does not improve the detection and outcome of fetal growth restriction.
“Although both the NICHD and WHO studies identified racial/ethnic differences in fetal growth, evidence to date indicates that the use of these new formulas in clinical practice does not improve the detection and outcome of FGR.51e53”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 51e53
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In some studies, the use of customized growth standards has been shown to improve the ability to distinguish growth-restricted fetuses from constitutionally small fetuses.
“In some studies, the use of customized growth standards has been shown to improve the ability to distinguish growthrestricted fetuses from constitutionally small fetuses.45e47”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 45e47
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Evidence supports the use of abdominal circumference as a diagnostic criterion for fetal growth restriction.
“Evidence supports the use of AC as a diagnostic criterion for FGR.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [31] David, 1996, Receiver-operator characteristic curves for the ultrasonographic prediction of small-for-gestational-age fetuses in low-risk pregnancies, Am J Obstet Gynecol source
- cites [32] Blue, 2017, Abdominal Circumference Alone versus Estimated Fetal Weight after 24 Weeks to Predict Small or Large for Gestational Age at Birth: A Meta-Analysis, Am J Perinatol source
- cites [33] Caradeux, 2019, Diagnostic performance of third-trimester ultrasound for the prediction of late-onset fetal growth restriction: a systematic review and meta-analysis, Am J Obstet Gynecol source
- Premisecitation
For birthweights in the range of 1000-4500 g, formulas based on 3 or 4 fetal biometric indices were significantly more accurate in estimating fetal weights than formulas based on 1 or 2 indices.
“For birthweights in the range of 1000e4500 g, formulas based on 3 or 4 fetal biometric indices were significantly more accurate in estimating fetal weights than formulas based on 1 or 2 indices.39”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [39] Melamed, 2009, Sonographic fetal weight estimation: which model should be used?, J Ultrasound Med source
- Premisecitation
There is significant variation in the diagnostic criteria used for fetal growth restriction.
“However, there is significant variation in the diagnostic criteria used for FGR.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [28] Gordijn, 2016, Consensus definition of fetal growth restriction: a Delphi procedure, Ultrasound Obstet Gynecol source
- Premisecitation
In a preterm population in France, the INTERGROWTH-21st formula was associated with a higher mean percentage error and a higher underestimation of birthweight at >28 weeks of gestation when compared with Hadlock.
“In a preterm population in France, the INTER-GROWTH-21st formula was associated with a higher mean percentage error and a higher underestimation of birthweight at >28 weeks of gestation when compared with Hadlock.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [53] Monier, 2018, Comparison of the Hadlock and INTERGROWTH formulas for calculating estimated fetal weight in a preterm population in France, Am J Obstet Gynecol source
- Premisecitation
In a prospective study in 1000 low-risk pregnancies, an abdominal circumference of less than the 10th percentile was found to have diagnostic accuracy similar to estimated fetal weight less than the 10th percentile for the prediction of small for gestational age.
“In a prospective study in 1000 low-risk pregnancies, an AC of less than the 10th percentile was found to have diagnostic accuracy similar to EFW less than the 10th percentile for the prediction of SGA. 31”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] David, 1996, Receiver-operator characteristic curves for the ultrasonographic prediction of small-for-gestational-age fetuses in low-risk pregnancies, Am J Obstet Gynecol source
- Interpretationcitation
An estimated fetal weight below the third percentile represents a more severe form of fetal growth restriction.
“Therefore, an EFW below the third percentile has been found to represent a more severe form of FGR.”
Quote in the paperSubstantial claim - Premisecitation
As early as 14 weeks of gestation, low impedance of the fetal placental circulation permits continuous forward flow in the umbilical artery throughout the cardiac cycle.
“As early as 14 weeks of gestation, low impedance of the fetal placental circulation permits continuous forward flow in the umbilical artery throughout the cardiac cycle.95”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Trudinger, 1992, Doppler ultrasonography and fetal well-being
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In a cohort of 656 pregnancies with fetal growth restriction, a gestational age of 32 weeks at diagnosis was identified as the optimal cutoff to maximize the differences in associated comorbidities and pregnancy outcomes between early- and late-onset fetal growth restriction.
“In a cohort of 656 pregnancies with FGR, a gestational age of 32 weeks at diagnosis was identified as the optimal cutoff to maximize the differences in associated comorbidities and pregnancy outcomes between early-and late-onset FGR.54”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [54] Savchev, 2014, Evaluation of an optimal gestational age cut-off for the definition of early- and late-onset fetal growth restriction, Fetal Diagn Ther source
- Premisecitation
Head circumference to abdominal circumference ratio was not found to be an independent predictor of adverse pregnancy outcomes.
“Furthermore, HC/AC was not found to be an independent predictor of adverse pregnancy outcomes.67”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] David, 1995, The head-to-abdomen circumference ratio: a reappraisal, Ultrasound Obstet Gynecol source
- Premisecitation
More recent studies have identified a 4%-10% incremental yield of chromosomal microarray analysis over karyotype in fetuses with early-onset growth restriction and no structural malformations.
“More recent studies have evaluated the role of CMA in fetuses with early-onset growth restriction and no structural malformations; such studies have identified a 4%e10% incremental yield of CMA over karyotype.88e90”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 88e90
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Fetuses classified as growth restricted by Hadlock, but not by the NICHD growth standard, had significantly higher composite morbidity than fetuses of normal growth.
“Fetuses classified as growth restricted by Hadlock, but not by the NICHD growth standard, had significantly higher composite morbidity than fetuses of normal growth.51”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Blue, 2018, Comparing the Hadlock fetal growth standard to the Eunice Kennedy Shriver National Institute of Child Health and Human Development racial/ethnic standard for the prediction of neonatal morbidity and small for gestational age, Am J Obstet Gynecol source
- Premisecitation
An estimated fetal weight below the third percentile has been associated with an increased risk of adverse perinatal outcome irrespective of umbilical and middle cerebral artery Doppler indices.
“An EFW below the third percentile has also been associated with an increased risk of adverse perinatal outcome irrespective of umbilical and middle cerebral artery Doppler indices.10”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Savchev, 2012, Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices, Ultrasound Obstet Gynecol source
- Premisecitation
The presence of abnormal umbilical artery Doppler indices has been found to predict adverse perinatal outcomes.
“The presence of abnormal umbilical artery Doppler indices has been found to predict adverse perinatal outcomes.62”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Unterscheider, 2013, Predictable progressive Doppler deterioration in IUGR: does it really exist?, Am J Obstet Gynecol source
- Premisecitation
In another prospective cohort study of 48 pregnancies with fetal growth restriction, 1 newborn (2.1%) was diagnosed with congenital cytomegalovirus.
“In another prospective cohort study of 48 pregnancies with FGR, 1 newborn (2.1%) was diagnosed with congenital CMV.92”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [92] Tsuge, 2019, Prospective Cohort Study of Congenital Cytomegalovirus Infection during Pregnancy with Fetal Growth Restriction: Serologic Analysis and Placental Pathology, J Pediatr source
- Premisecitation
Two (0.6%) of the fetuses with congenital cytomegalovirus had no ultrasonographic findings other than fetal growth restriction.
“Two (0.6%) of the fetuses with congenital CMV had no ultrasonographic findings other than FGR.91”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [91] Yamamoto, 2013, Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction, J Obstet Gynaecol Res source
- Premisecitation
Growth and developmental delay from birth to age 4 years have been shown to be similar in symmetric and asymmetric growth-restricted preterm newborns.
“More recently, growth and developmental delay have been evaluated from birth to the age of 4 years and shown to be similar in symmetric and asymmetric growth-restricted preterm newborns.66”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Bocca-Tjeertes, 2014, Symmetrical and asymmetrical growth restriction in preterm-born children, Pediatrics source
- Premisecitation
In a systematic review that included fetuses with no structural malformations, the mean rate of chromosomal abnormalities was 6.4%.
“Although chromosome abnormalities are more frequent in pregnancies with structural anomalies and FGR, in a systematic review that included fetuses with no structural malformations, the mean rate of chromosomal abnormalities was 6.4%.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [87] Sagi-Dain, 2017, Risk for chromosomal aberrations in apparently isolated intrauterine growth restriction: A systematic review, Prenat Diagn source
- Premisecitation
Prophylactic low-dose aspirin was shown to provide a modest risk reduction in fetal growth restriction and small for gestational age in 2 meta-analyses.
“The use of prophylactic lowdose aspirin was shown to provide a modest risk reduction in FGR and SGA in 2 meta-analyses.72,73”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [72] Roberge, 2017, The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis, Am J Obstet Gynecol source
- cites [73] Meher, 2017, Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis, Am J Obstet Gynecol source
- Premisecitation
After correction for prematurity, survival without neurologic impairment was significantly higher in the group delivered according to late ductus venosus changes (95%) compared with cSTV (85%).
“After correction for prematurity, survival without neurologic impairment was found to be significantly higher in the group delivered according to late ductus venosus changes (95%) compared with cSTV (85%).16”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Lees, 2015, 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial, Lancet source
- Premisecitation
15%e20% of late-onset growth-restricted fetuses with normal umbilical blood flow have middle cerebral artery Doppler findings of cerebral vasodilation.
“Studies have found that 15%e20% of late-onset growthrestricted fetuses with normal umbilical blood flow have middle cerebral artery Doppler findings of cerebral vasodilation, and CPR has also been studied for its utility in predicting adverse outcomes and guiding the timing of delivery in late-onset cases.101,115,132e137”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 101,115,132e137
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
A normal umbilical artery Doppler in late-onset FGR does not rule out placental disease.
“therefore, the presence of a normal umbilical artery Doppler in late-onset FGR does not rule out placental disease.105,106”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationreasoning
Results of TRUFFLE cannot be generalized to the visual interpretation of CTG.
“results cannot be generalized to the visual interpretation of CTG.”
Quote in the paperSubstantial claim - Premisecitation
Even in pregnancies with AEDV/REDV of the umbilical artery, late Doppler abnormalities of the ductus venosus are noted in only about 41% of fetuses.
“Even in pregnancies with AEDV/REDV of the umbilical artery, late Doppler abnormalities of the ductus venosus are noted in only about 41% of fetuses.117”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [117] Schwarze, 2005, Qualitative venous Doppler flow waveform analysis in preterm intrauterine growth-restricted fetuses with ARED flow in the umbilical artery--correlation with short-term outcome, Ultrasound Obstet Gynecol source
- Premisecitation
Pooled data from the meta-analysis revealed a risk of stillbirth of 6.8% for AEDV and 19% for REDV in the umbilical artery or ductus venosus.
“Pooled data from this meta-analysis also revealed a risk of stillbirth of 6.8% for AEDV and 19% for REDV in the umbilical artery or ductus venosus.100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Caradeux, 2018, Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis, Am J Obstet Gynecol source
- Premisecitation
Reversed A-wave of the ductus venosus in FGR signifies more significant fetal cardiac compromise.
“Reversed A-wave of the ductus venosus in FGR signifies more significant fetal cardiac compromise.119”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [119] Yagel, 2010, The fetal venous system, Part II: ultrasound evaluation of the fetus with congenital venous system malformation or developing circulatory compromise, Ultrasound Obstet Gynecol source
- Premisecitation
Experimental modeling suggests that a threshold of placental vascular obliteration is required before umbilical artery Doppler abnormalities are seen.
“Experimental modeling suggests that a threshold of placental vascular obliteration is required before umbilical artery Doppler abnormalities are seen; therefore, the presence of a normal umbilical artery Doppler in late-onset FGR does not rule out placental disease.105,106”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
The poor prediction of adverse outcome by umbilical artery Doppler in late-onset FGR is probably related to the lower frequency of placental pathologic findings in late-onset FGR compared with early-onset FGR.
“This result is probably related to the lower frequency of placental pathologic findings in late-onset FGR when compared with early-onset FGR.102e104”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 102e104
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In a large study on FGR, the mean time-to-delivery interval for umbilical artery PI greater than the 95th percentile, AEDV, and REDV was 26, 13, and 4 days, respectively.
“In a large study on FGR, the mean timeto-delivery interval for umbilical artery PI greater than the 95th percentile, AEDV, and REDV was 26, 13, and 4 days, respectively.62”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [62] Unterscheider, 2013, Predictable progressive Doppler deterioration in IUGR: does it really exist?, Am J Obstet Gynecol source
- Premisecitation
In general, variation in umbilical artery Doppler end-diastolic flow along the umbilical cord is minimal and not significant enough to affect clinical decision-making.
“In general, this variation in umbilical artery Doppler end-diastolic flow along the umbilical cord is minimal and not significant enough to affect clinical decision-making.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Trudinger, 1992, Doppler ultrasonography and fetal well-being
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
Data from PORTO showed that CPR evaluation had a sensitivity of 66% and specificity of 85% for prediction of adverse outcomes.
“Data from this study showed that CPR evaluation had a sensitivity of 66% and specificity of 85% for the prediction of adverse outcomes.138”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [138] Flood, 2014, The role of brain sparing in the prediction of adverse outcomes in intrauterine growth restriction: results of the multicenter PORTO Study, Am J Obstet Gynecol source
- Premisecitation
In FGR, Doppler abnormalities of the ductus venosus primarily reflect increased central venous pressure, resulting from increased right ventricular end-diastolic pressure and decreased cardiac muscle compliance.
“In FGR, Doppler abnormalities of the ductus venosus primarily reflect increased central venous pressure, resulting from increased right ventricular end-diastolic pressure and decreased cardiac muscle compliance.110,118”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [110] Baschat, 2005, Arterial and venous Doppler in the diagnosis and management of early onset fetal growth restriction, Early Hum Dev source
- cites [118] Abuhamad, 2016
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation
The progression from an abnormal umbilical artery Doppler with decreased diastolic flow to AEDV/REDV can take several days to weeks, especially in the absence of maternal disease.
“The progression from an abnormal umbilical artery Doppler with a decreased diastolic flow to AEDV/REDV can take several days to weeks, especially in the absence of maternal disease.”
Quote in the paperNot a substantial claim - Premisecitation
Abnormal uterine artery Doppler, defined as a PI greater than the 95th percentile for gestational age or a diastolic notch, has been associated with adverse pregnancy outcomes, including preeclampsia, FGR, and perinatal mortality.
“Abnormal uterine artery Doppler, defined as a PI greater than the 95th percentile for gestational age or the presence of a diastolic notch, has been associated with adverse pregnancy outcomes, including preeclampsia, FGR, and perinatal mortality.137,141e147”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 137,141e147
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In a large European study, birthweights between the 10th and 25th percentiles were associated with a 2-fold increase in mortality compared with the 50th to 75th percentile weight group.
“In a large European study, birthweights between the 10th and 25th percentiles were associated with a 2-fold increase in mortality when compared with the 50th to 75th percentile weight group.167”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [167] Zeitlin, 2010, Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort, J Pediatr source
- Premisecitation
Severe early-onset FGR is characterized by failure of trophoblastic invasion of the myometrial spiral arteries, resulting in reduced uteroplacental perfusion.
“Severe early-onset FGR is characterized by failure of trophoblastic invasion of the myometrial spiral arteries, resulting in reduced uteroplacental perfusion.140”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [140] Sciscione, 2009, Uterine artery Doppler flow studies in obstetric practice, Am J Obstet Gynecol source
- Premisecitation
In a retrospective cohort study of pregnancies with FGR, no difference in composite neonatal outcome was seen between delivery at 39 weeks in fetuses with normal umbilical artery Doppler and delivery at 37 weeks in fetuses with elevated umbilical artery S/D ratio.
“In a retrospective cohort study of pregnancies with FGR, no difference in composite neonatal outcome was seen between delivery at 39 weeks of gestation in fetuses with normal umbilical artery Doppler and delivery at 37 weeks of gestation in fetuses with elevated umbilical artery S/D ratio.168”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [168] Maggio, 2015, Perinatal outcomes with normal compared with elevated umbilical artery systolic-to-diastolic ratios in fetal growth restriction, Obstet Gynecol source
- Premisecitation
In the periviable period, the decision for delivery may be challenging because rates of perinatal death, neurodevelopmental impairment, and other adverse outcomes are high in this gestational age window.
“In the periviable period, the decision for delivery may be challenging because the rates of perinatal death, neurodevelopmental impairment, and other adverse outcomes are high in this gestational age window.157e159”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 157e159
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The PORTO study, including more than 1100 pregnancies with FGR, noted that amniotic fluid volume abnormalities did not independently increase the risk for adverse outcomes in FGR.
“The PORTO study, which included more than 1100 pregnancies with FGR, noted that amniotic fluid volume abnormalities did not independently increase the risk for adverse outcomes in FGR. 30”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] Unterscheider, 2013, Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study, Am J Obstet Gynecol source
- Premisecitation
Survival of very preterm neonates gradually decreases with decreasing weight percentiles.
“Survival of very preterm neonates gradually decreases with decreasing weight percentiles.160e163”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 160e163
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
In normal pregnancies, spiral artery remodeling results in a low-impedance circulation, reflected in the uterine arteries by high velocity and continuous forward flow in diastole.
“In normal pregnancies, spiral artery remodeling results in a lowimpedance circulation, which is reflected in the uterine arteries by the presence of high velocity and continuous forward flow in diastole.140”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [140] Sciscione, 2009, Uterine artery Doppler flow studies in obstetric practice, Am J Obstet Gynecol source
- Premisecitation
There is currently a paucity of data on the role of amniotic fluid volume measurement in FGR management and delivery.
“There is currently a paucity of data on the role of amniotic fluid volume measurement in FGR management and delivery.30”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Unterscheider, 2013, Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study, Am J Obstet Gynecol source
- Interpretationreasoning
Based on the available evidence, uterine artery Doppler does not add clinically valuable information for diagnosis or management of FGR.
“Based on the available evidence, uterine artery Doppler does not add clinically valuable information for diagnosis or management.”
Quote in the paperSubstantial claim - Interpretationcitation
In the presence of REDV, neonatal morbidity and mortality rates are higher than complications of prematurity at 30e32 weeks of gestation.
“In the presence of REDV, neonatal morbidity and mortality rates are higher than complications of prematurity at 30e32 weeks of gestation.100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Caradeux, 2018, Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis, Am J Obstet Gynecol source
- Interpretationcitation
Neonatal morbidity and mortality rates associated with AEDV are higher than rates of complications of prematurity at 33e34 weeks of gestation.
“As discussed previously, neonatal morbidity and mortality rates associated with AEDV are higher than rates of complications of prematurity at 33e34 weeks of gestation.100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Caradeux, 2018, Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis, Am J Obstet Gynecol source
- Premisecitation
A large US cohort study reported that delivery at 37 weeks of gestation results in a decrease in the stillbirth rate in the presence of risk factors, such as FGR.
“A large US cohort study reported that delivery at 37 weeks of gestation results in a decrease in the stillbirth rate in the presence of risk factors, such as FGR.169”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [169] Trudell, 2013, Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses, Am J Obstet Gynecol source
- Premisecitation
Neonatal mortality in SGA infants born between 24 and 29 weeks of gestation is increased 2-fold to 4-fold compared with appropriately grown neonates.
“Neonatal mortality in SGA infants born between 24 and 29 weeks of gestation is increased 2-fold to 4-fold when compared with appropriately grown neonates.4,164e166”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 4,164e166
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Premisecitation
The evidence supporting the timing of delivery in pregnancies with FGR and abnormal umbilical artery Doppler but without AEDV/REDV is limited.
“The evidence supporting the timing of delivery in pregnancies with FGR and abnormal umbilical artery Doppler but without AEDV/REDV is limited.168”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [168] Maggio, 2015, Perinatal outcomes with normal compared with elevated umbilical artery systolic-to-diastolic ratios in fetal growth restriction, Obstet Gynecol source
- Premisecitation
Older studies reported rates of intrapartum fetal heart rate decelerations requiring cesarean delivery in 75%e95% of pregnancies with FGR and AEDV/REDV.
“Older studies reported rates of intrapartum fetal heart rate decelerations requiring cesarean delivery in 75%e95% of pregnancies with FGR and AEDV/REDV.172,173”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [172] Karsdorp, 1994, Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery, Lancet source
- cites [173] Forouzan, 1995, Absence of end-diastolic flow velocity in the umbilical artery: a review, Obstet Gynecol Surv source
- Rests on an assumption: The decision for delivery in FGR is driven by fetal and maternal factors.
- May combine two claims. 32
- Classified as probably not a substantial claim. 5
May combine two claims.
PremisecitationSuboptimal perfusion of the maternal placental circulation is the most common cause of fetal growth restriction and accounts for 25%-30% of all cases.
“Suboptimal perfusion of the maternal placental circulation is the most common cause of FGR and accounts for 25e30% of all cases.2,3”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [2] Bamfo, 2011, Diagnosis and management of fetal growth restriction, J Pregnancy source
Section 2.1 (Causes; page unavailable) says maternal vascular disease and thrombophilia can cause uteroplacental hypoperfusion that impairs fetal growth. Section 2.2 also discusses inadequate placentation in pregnancies with FGR. Neither section establishes that suboptimal maternal placental perfusion is the most common cause or accounts for 25–30% of all FGR cases; the 20–30% figure in section 2.1 concerns dichorionic twin pregnancies. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [3] Resnik, 2002, Intrauterine growth restriction, Obstet Gynecol source
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChromosomal disorders and congenital malformations are responsible for approximately 20% of fetal growth restriction cases.
“Chromosomal disorders and congenital malformations are responsible for approximately 20% of FGR cases.2,3”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [2] Bamfo, 2011, Diagnosis and management of fetal growth restriction, J Pregnancy source
Section 2.1 (Causes; page unavailable) identifies aneuploidy and fetal malformations as less-common fetal causes of FGR. It does not say they account for approximately 20% of cases. Its figure of over 20% refers instead to confined placental mosaicism among fetuses with idiopathic FGR. (LLM, conf=0.87)
Experimental — accuracy not yet measured - cites [3] Resnik, 2002, Intrauterine growth restriction, Obstet Gynecol source
May combine two claims.
PremisecitationMaternal hypertensive disease is common in early-onset fetal growth restriction and plays an important role in pregnancy outcomes.
“Maternal hypertensive disease is common in early-onset FGR and plays an important role in pregnancy outcomes.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
May combine two claims.
PremisecitationIn late-onset fetal growth restriction, cardiovascular adaptation is typically limited to the cerebral circulation and is commonly associated with normal Doppler of the umbilical arteries.
“In contrast, cardiovascular adaptation of late-onset FGR is typically limited to the cerebral circulation and is commonly associated with normal Doppler of the umbilical arteries.57,60,61”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [57] Parra-Saavedra, 2014, Neurodevelopmental outcomes of near-term small-for-gestational-age infants with and without signs of placental underperfusion, Placenta source
- cites [60] Figueras, 2008, Small-for-gestational-age fetuses with normal umbilical artery Doppler have suboptimal perinatal and neurodevelopmental outcome, Eur J Obstet Gynecol Reprod Biol source
- cites [61] Severi, 2002, Uterine and fetal cerebral Doppler predict the outcome of third-trimester small-for-gestational age fetuses with normal umbilical artery Doppler, Ultrasound Obstet Gynecol source
The Introduction (page unavailable) describes cerebral blood-flow redistribution as a fetal response to mild hypoxemia, and the Discussion (page unavailable) examines abnormal middle cerebral artery Doppler in third-trimester small-for-gestational-age fetuses with normal umbilical artery Doppler. But normal umbilical Doppler was an inclusion criterion, so the study does not establish that it is common across late-onset growth restriction or that cardiovascular adaptation is typically limited to the cerebral circulation. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationLate-onset fetal growth restriction represents approximately 70%-80% of fetal growth restriction cases and is typically milder in presentation.
“Late-onset FGR represents approximately 70%e80% of FGR cases and is typically milder in presentation.55,56”
Quote in the paperNot a substantial claim1 of 2 sources checkedMay combine two claims.
PremisecitationPregnant women with hypertension had a significantly shorter median interval from study enrollment to delivery, and newborns of mothers with hypertension were delivered at an earlier gestational age and had lower birthweights.
“Pregnant women with hypertension had a significantly shorter median interval from study enrollment to delivery, and newborns of mothers with hypertension were delivered at an earlier gestational age and had lower birthweights.80”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
May combine two claims.
PremisecitationIn a large retrospective cohort of more than 3 million singleton pregnancies, the risk of stillbirth at birthweights of less than the 3rd percentile was increased approximately 3-fold over the 3rd to 5th percentile group at nearly all gestational ages, and there was an increased risk of 4-fold to 7-fold over the 5th to 10th percentile group.
“In a large retrospective cohort of more than 3 million singleton pregnancies, the risk of stillbirth at birthweights of less than the 3rd percentile was increased approximately 3-fold over the 3rd to 5th percentile group at nearly all gestational ages, and there was an increased risk of 4-fold to 7-fold over the 5th to 10th percentile group.63”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [63] Pilliod, 2012, The risk of intrauterine fetal death in the small-for-gestational-age fetus, Am J Obstet Gynecol source
May combine two claims.
PremisecitationIn TRUFFLE, maternal hypertension was present in 50% of pregnancies during the study and 70% of pregnancies at the time of delivery.
“In TRUFFLE, maternal hypertension was present in 50% of pregnancies during the study and 70% of pregnancies at the time of delivery.”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
The Results (page unavailable in our copy) report that 368 women (73%) had a hypertensive condition at delivery, supporting the claim's approximate 70%. They do not report 50% during the study; instead, they say the proportion with a gestational hypertensive condition increased by 13% between study entry and delivery. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe pulsatility index, resistance index, or systolic-to-diastolic ratio can be used for quantification of the Doppler waveform in the umbilical artery, although recent studies have generally used either the pulsatility index or resistance index.
“The pulsatility index (PI), resistance index (RI), or systolicto-diastolic (S/D) ratio can be used for quantification of the Doppler waveform in the umbilical artery, although recent studies have generally used either the PI or RI.5,16,28,30,80,83”
Quote in the paperNot a substantial claim3 of 6 sources checked- cites [5] Unterscheider, 2014, Fetal growth restriction and the risk of perinatal mortality-case studies from the multicentre PORTO study, BMC Pregnancy Childbirth source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [16] Lees, 2015, 2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial, Lancet source
- cites [28] Gordijn, 2016, Consensus definition of fetal growth restriction: a Delphi procedure, Ultrasound Obstet Gynecol source
- cites [30] Unterscheider, 2013, Optimizing the definition of intrauterine growth restriction: the multicenter prospective PORTO Study, Am J Obstet Gynecol source
- cites [80] Lees, 2013, Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE), Ultrasound Obstet Gynecol source
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [83] Baschat, 2007, Predictors of neonatal outcome in early-onset placental dysfunction, Obstet Gynecol source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationIncorporation of umbilical artery Doppler evaluation in the management of high-risk pregnancies significantly reduces the risk of perinatal death, induction of labor, and cesarean delivery.
“Incorporation of umbilical artery Doppler evaluation in the management of high-risk pregnancies has been shown to significantly reduce the risk of perinatal death, induction of labor, and cesarean delivery.”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [96] McCowan, 2000, A pilot randomized controlled trial of two regimens of fetal surveillance for small-for-gestational-age fetuses with normal results of umbilical artery doppler velocimetry, Am J Obstet Gynecol source
- cites [97] Alfirevic, 2017, Fetal and umbilical Doppler ultrasound in high-risk pregnancies, Cochrane Database Syst Rev source
- Rests on an assumption: An abnormal umbilical artery Doppler waveform reflects the presence of placental insufficiency and can help differentiate the growth-restricted fetus from the constitutionally small fetus.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationProtocols for umbilical artery Doppler in FGR surveillance vary from weekly to a 2-to 4-week interval.
“Protocols vary from weekly umbilical artery Doppler to a 2-to 4-week interval.24,108”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [24] McCowan, 2018, Evidence-based national guidelines for the management of suspected fetal growth restriction: comparison, consensus, and controversy, Am J Obstet Gynecol source
Table 4 (Conclusions; page not supplied) shows that recommended umbilical artery Doppler intervals vary, including weekly and every two weeks, depending on the guideline and Doppler findings. The Results section gives a 2–4-week interval for ongoing growth scans, not umbilical artery Doppler, so the claimed four-week Doppler interval is unsupported. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [108] Turan, 2008, Progression of Doppler abnormalities in intrauterine growth restriction, Ultrasound Obstet Gynecol source
The Discussion recommends weekly umbilical artery Doppler examinations after IUGR is diagnosed. It does not recommend a 2-to-4-week Doppler interval; its reference to the next two weeks concerns whether abnormalities develop, not how often to test. (LLM, conf=0.87)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationA large systematic review and meta-analysis on the prognostic accuracy of CPR and middle cerebral artery Doppler for adverse perinatal outcomes in FGR revealed few high-quality studies and reported large variations in sensitivity and specificity.
“However, a large systematic review and metaanalysis on the prognostic accuracy of CPR and middle cerebral artery Doppler for adverse perinatal outcomes in FGR revealed few high-quality studies and reported large variations in sensitivity and specificity.139”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [139] Vollgraff Heidweiller-Schreurs, 2018, Prognostic accuracy of cerebroplacental ratio and middle cerebral artery Doppler for adverse perinatal outcome: systematic review and meta-analysis, Ultrasound Obstet Gynecol source
May combine two claims.
PremisecitationIntact survival was 0% at 24 weeks, 13% at 25 weeks, and 6%e31% at 26 weeks of gestation.
“Intact survival was 0% at 24 weeks, 13% at 25 weeks, and 6%e31% at 26 weeks of gestation.159”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [159] Visser, 2014, Fetal growth restriction at the limits of viability, Fetal Diagn Ther source
May combine two claims.
PremisecitationAlthough FGR detection rates >90% have been reported in first- and second-trimester prediction models combining maternal factors, biochemical markers, and uterine artery Doppler, lack of external validation or demonstration of improved pregnancy outcomes limits their clinical applicability.
“Although FGR detection rates >90% have been reported in firstand second-trimester prediction models that combine maternal factors, biochemical markers, and uterine artery Doppler, lack of external validation or demonstration of improved pregnancy outcomes limits their clinical applicability.145,150,151”
Quote in the paperSubstantial claim2 of 3 sources checked- cites [145] Poon, 2015, Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 19-24 weeks, Ultrasound Obstet Gynecol source
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [150] Karagiannis, 2011, Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks, Fetal Diagn Ther source
- cites [151] Cruz-Martinez, 2015, Clinical utility of third-trimester uterine artery Doppler in the prediction of brain hemodynamic deterioration and adverse perinatal outcome in small-for-gestational-age fetuses, Ultrasound Obstet Gynecol source
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationAnother systematic review and meta-analysis reported that abdominal circumference and estimated fetal weight performed similarly, and for a 10% fixed false-positive rate, abdominal circumference had higher sensitivity.
“Another systematic review and meta-analysis reported that AC and EFW performed similarly, and for a 10% fixed false-positive rate, AC had higher sensitivity.33”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Caradeux, 2019, Diagnostic performance of third-trimester ultrasound for the prediction of late-onset fetal growth restriction: a systematic review and meta-analysis, Am J Obstet Gynecol source
May combine two claims.
PremisecitationFetal growth restriction remains a complex obstetrical problem with disparate published diagnostic criteria, relatively low detection rates, and limited preventative and treatment options.
“FGR remains a complex obstetrical problem with disparate published diagnostic criteria, relatively low detection rates, and limited preventative and treatment options.22e25”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 22e25
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationCompared with other cutoffs, an abdominal circumference of less than the fifth percentile has significantly lower sensitivity but higher specificity in predicting small for gestational age.
“Compared with other cutoffs, an AC of less than the fifth percentile has significantly lower sensitivity but higher specificity in predicting SGA.32”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [32] Blue, 2017, Abdominal Circumference Alone versus Estimated Fetal Weight after 24 Weeks to Predict Small or Large for Gestational Age at Birth: A Meta-Analysis, Am J Perinatol source
May combine two claims.
PremisecitationFetuses with fetal growth restriction are not always small for gestational age at birth, and small-for-gestational-age neonates have often not been diagnosed as growth restricted on prenatal ultrasound.
“Fetuses with FGR are not always SGA at birth, and SGA neonates have often not been diagnosed as growth restricted on prenatal ultrasound.27”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [27] Monier, 2017, Fetal and neonatal outcomes of preterm infants born before 32 weeks of gestation according to antenatal vs postnatal assessments of restricted growth, Am J Obstet Gynecol source
May combine two claims.
PremisecitationStudies have shown an association between fetal growth restriction and long-term neurologic impairment, with rates of cognitive and learning disabilities as high as 20%-40% by school age.
“In addition, studies have shown an association between FGR and long-term neurologic impairment, 15e20 with rates of cognitive and learning disabilities as high as 20%e40% by school age.21”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites 15e20
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [21] Leitner, 2007, Neurodevelopmental outcome of children with intrauterine growth retardation: a longitudinal, 10-year prospective study, J Child Neurol source
May combine two claims.
PremisecitationThe Hadlock formula classified more infants within 10% of actual birthweight and was more accurate than INTERGROWTH-21st in the overall estimation of weight for fetuses delivered between 22 and 34 weeks of gestation.
“The Hadlock formula classified more infants within 10% of actual birthweight and was more accurate than the INTERGROWTH-21st in the overall estimation of weight for fetuses delivered between 22 and 34 weeks of gestation.53”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [53] Monier, 2018, Comparison of the Hadlock and INTERGROWTH formulas for calculating estimated fetal weight in a preterm population in France, Am J Obstet Gynecol source
May combine two claims.
PremisecitationEarly-onset fetal growth restriction is typically more severe, tends to follow an established Doppler pattern of fetal deterioration, is more commonly associated with maternal hypertensive disorders of pregnancy, and shows more significant placental dysfunction than late-onset fetal growth restriction.
“The clinical spectrum of early-and late-onset FGR also differs; early-onset FGR is typically more severe, tends to follow an established Doppler pattern of fetal deterioration, is more commonly associated with maternal hypertensive disorders of pregnancy, and shows more significant placental dysfunction than late-onset FGR.23,28,54e56”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 23,28,54e56
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThe Hadlock formula better predicted small for gestational age and composite neonatal morbidity at birth and had a lower ultrasound-to-birthweight percentile discrepancy than the NICHD growth standard.
“The Hadlock formula better predicted SGA and composite neonatal morbidity at birth and had a lower ultrasound-to-birthweight percentile discrepancy than the NICHD growth standard.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [51] Blue, 2018, Comparing the Hadlock fetal growth standard to the Eunice Kennedy Shriver National Institute of Child Health and Human Development racial/ethnic standard for the prediction of neonatal morbidity and small for gestational age, Am J Obstet Gynecol source
May combine two claims.
PremisecitationUnlike early-onset fetal growth restriction, late-onset fetal growth restriction is less likely to be associated with maternal hypertensive disorders and typically has less extensive placental histopathologic findings of underperfusion.
“Unlike early-onset FGR, late-onset FGR is less likely to be associated with maternal hypertensive disorders and typically has less extensive placental histopathologic findings of underperfusion.57e59”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites 57e59
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationThere is no consistent evidence that nutritional and dietary supplements or bed rest prevents fetal growth restriction or reduces the incidence of small-for-gestational-age births.
“There is no consistent evidence that nutritional and dietary supplements or bed rest prevents FGR or reduces the incidence of SGA births.68e71”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 68e71
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationIn a study of 319 pregnancies, no cases of maternal or congenital infection with toxoplasma, rubella, or herpes were found, whereas 6 (1.8%) fetuses were diagnosed as having congenital cytomegalovirus.
“The association of maternal infections with FGR was recently evaluated in a study that included 319 pregnancies.No cases of maternal or congenital infection with toxoplasma, rubella, or herpes were found, whereas 6 (1.8%) fetuses were diagnosed as having congenital cytomegalovirus (CMV).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [91] Yamamoto, 2013, Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction, J Obstet Gynaecol Res source
May combine two claims.
PremisecitationWaveforms obtained near the placental end of the cord reflect downstream impedance and show higher end-diastolic blood flow velocity than waveforms obtained near the fetal cord insertion.
“Waveforms obtained near the placental end of the cord reflect downstream impedance and show higher end-diastolic blood flow velocity than waveforms obtained near the fetal cord insertion.95”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [95] Trudinger, 1992, Doppler ultrasonography and fetal well-being
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
PremisecitationIn a meta-analysis of 35 studies, abnormal middle cerebral artery Doppler had a low likelihood ratio for prediction of perinatal mortality (LR 1.36 [1.10e1.67]) and adverse perinatal outcome (LR 2.77 [1.93e3.96]).
“In a meta-analysis of 35 studies, abnormal middle cerebral artery Doppler had a low likelihood ratio (LR) for prediction of perinatal mortality (LR 1.36 [1.10e1.67])and adverse perinatal outcome (LR 2.77 [1.93e3.96]).130”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [130] Morris, 2012, Systematic review and meta-analysis of middle cerebral artery Doppler to predict perinatal wellbeing, Eur J Obstet Gynecol Reprod Biol source
May combine two claims.
PremisecitationLongitudinal studies have shown that Doppler abnormalities of the ductus venosus in FGR reflect an advanced stage of fetal compromise, associated with increased perinatal morbidity and mortality.
“Longitudinal studies have shown that Doppler abnormalities of the ductus venosus in FGR reflect an advanced stage of fetal compromise, associated with increased perinatal morbidity and mortality.2,23,55,110e117”
Quote in the paperSubstantial claim0 of 1 sources checked- cites 2,23,55,110e117
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe middle cerebral artery is the largest vessel of the fetal cerebral circulation and carries about 80% of cerebral blood flow.
“The middle cerebral artery is the largest vessel of the fetal cerebral circulation and carries about 80% of cerebral blood flow.122”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [122] Veille, 1993, Longitudinal quantitation of middle cerebral artery blood flow in normal human fetuses, Am J Obstet Gynecol source
May combine two claims.
InterpretationcitationAEDV/REDV in the umbilical artery reflects significant placental deterioration and is associated with high perinatal mortality.
“AEDV/REDV in the umbilical artery reflects the presence of significant placental deterioration and is associated with high perinatal mortality.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningDoppler abnormalities of the ductus venosus in the setting of a normal umbilical artery Doppler indicate an alternative pathophysiological etiology, possibly related to fetal cardiac, vascular, or genetic abnormalities, and are most often not reflective of significant placental disease.
“Doppler abnormalities of the ductus venosus in the setting of a normal umbilical artery Doppler indicate an alternative pathophysiological etiology, possibly related to the presence of fetal cardiac, vascular, or genetic abnormalities, and thus are most often not reflective of significant placental disease.”
Quote in the paperSubstantial claimMay combine two claims.
Premisenone givenAbsent or reversed A-wave of the ductus venosus represents an advanced stage of fetal compromise and is uncommon.
“Furthermore, absent or reversed A-wave of the ductus venosus represents an advanced stage of fetal compromise and is uncommon.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationA meta-analysis of FGR at <34 weeks reported an odds ratio for stillbirth of 11.16 (95% CI, 6.31e19.73) for absent or reversed A-wave of the ductus venosus, a stillbirth frequency of 20%, and a stillbirth risk of 46% with a reversed A-wave.
“A meta-analysis of FGR at <34 weeks of gestation reported odds ratios for stillbirth of 11.16 (95% CI, 6.31e19.73)for absent or reversed A-wave of the ductus venosus and a frequency of stillbirth of 20%; the risk of stillbirth with a reversed A-wave was 46%. 100”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [100] Caradeux, 2018, Risk of fetal death in growth-restricted fetuses with umbilical and/or ductus venosus absent or reversed end-diastolic velocities before 34 weeks of gestation: a systematic review and meta-analysis, Am J Obstet Gynecol source
May combine two claims.
PremisecitationGrowth-restricted fetuses, particularly those with AEDV/REDV, are at increased risk for decelerations in labor, emergency cesarean delivery, and metabolic acidemia at delivery.
“Growth-restricted fetuses, particularly those with AEDV/REDV, are at an increased risk for decelerations in labor, emergency cesarean delivery, and metabolic acidemia at delivery.170,171”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [170] Lin, 1980, Acid-base characteristics of fetuses with intrauterine growth retardation during labor and delivery, Am J Obstet Gynecol source
- cites [171] Baschat, 2000, Umbilical artery doppler screening for detection of the small fetus in need of antepartum surveillance, Am J Obstet Gynecol source
- Rests on an assumption: The decision for delivery in FGR is driven by fetal and maternal factors.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFetal deterioration has been reported to be independently reflected by Doppler and BPP testing.
“fetal deterioration has been reported to be independently reflected by Doppler and BPP testing”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [155] Figueras, 2011, Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management, Am J Obstet Gynecol source
The paper relies on this without support.
CTG is currently accepted as the primary method for fetal surveillance in high-risk pregnancies in the United States.
“CTG is currently accepted as the primary method for fetal surveillance in high-risk pregnancies in the United States.”
The paper relies on this without support.
The decision for delivery in FGR is driven by fetal and maternal factors.
“The decision for delivery in FGR is driven by fetal and maternal factors.”
The paper relies on this without support.
An abnormal umbilical artery Doppler waveform reflects the presence of placental insufficiency and can help differentiate the growth-restricted fetus from the constitutionally small fetus.
“An abnormal umbilical artery Doppler waveform reflects the presence of placental insufficiency and can help differentiate the growth-restricted fetus from the constitutionally small fetus.”
The paper relies on this without support.
Fetal hypoxemia associated with growth restriction results in cerebral vasodilation, an early adaptive mechanism termed the brain-sparing effect.
“Fetal hypoxemia associated with growth restriction results in cerebral vasodilation, an early adaptive mechanism termed the brain-sparing effect.”
The paper relies on this without support.
Measurement of flow through the middle cerebral artery using Doppler can identify cerebral vasodilation, which can be quantified using PI or the cerebroplacental ratio (CPR).
“Measurement of flow through the middle cerebral artery using Doppler can identify cerebral vasodilation, which can be quantified using PI or the cerebroplacental ratio (CPR).”
The paper relies on this without support.
Uterine artery Doppler assesses the maternal component of placental blood flow and is a marker of remodeling of the spiral arteries by trophoblastic cellular invasion.
“Uterine artery Doppler assesses the maternal component of placental blood flow and is a marker of remodeling of the spiral arteries by trophoblastic cellular invasion.”
The paper relies on this without support.
This pregnancy adaptation optimizes the intervillous placental blood flow and delivery of oxygen and nutrients to the fetus.
“This pregnancy adaptation optimizes the intervillous placental blood flow and delivery of oxygen and nutrients to the fetus.”
The paper relies on this without support.
There are limited data to inform recommendations regarding the mode of delivery in pregnancies complicated by FGR.
“There are limited data to inform recommendations regarding the mode of delivery in pregnancies complicated by FGR.”
The paper relies on this without support.
More recent studies have questioned the value of BPP in fetal surveillance of high-risk pregnancies, including early-onset severe FGR, because of a high prevalence of false-positive and false-negative results.
“More recent studies have questioned the value of BPP in fetal surveillance of high-risk pregnancies, including early-onset severe FGR, because of a high prevalence of false-positive and false-negative results.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
CMV percentage does not match the reported study size
MinorSix cases among 319 pregnancies is 1.88%, which rounds to 1.9% rather than the reported 1.8%.
Reported 1.8 · recomputed 1.880878
“The association of maternal infections with FGR was recently evaluated in a study that included 319 pregnancies.No cases of maternal or congenital infection with toxoplasma, rubella, or herpes were found, whereas 6 (1.8%) fetuses were diagnosed as having congenital cytomegalovirus (CMV).”
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305 · see citing works
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik, D. L., Wright, D., Poon, L. C., O’Gorman, N., Syngelaki, A., de Paco Matallana, C., Akolekar, R., Cicero, S., Janga, D., Singh, M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1704559 · Cited by 2,287 · see citing works
Consensus definition of fetal growth restriction: a Delphi procedure: Consensus definition of FGR
Gordijn, S. J., Beune, I. M., Thilaganathan, B., Papageorghiou, A., Baschat, A. A., Baker, P. N., Silver, R. M., Wynia, K., & Ganzevoort, W. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15884 · Cited by 1,638 · see citing works
In utero analysis of fetal growth: a sonographic weight standard
Hadlock, F. P., Harrist, R. B., & Martinez-Poyer, J. (1991) · Radiology · doi:10.1148/radiology.181.1.1887021 · Cited by 1,281 · see citing works
Birth weight in relation to morbidity and mortality among newborn infants
McIntire, D. D., Bloom, S. L., Casey, B. M., & Leveno, K. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904223401603 · Cited by 1,258 · see citing works
Pathophysiology of placental-derived fetal growth restriction
Burton, G. J., & Jauniaux, E. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.577 · Cited by 1,070 · see citing works
Intrauterine growth restriction
Resnik, R. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(01)01780-x · Cited by 1,022 · see citing works
Papageorghiou, A. T., Ohuma, E. O., Altman, D. G., Todros, T., Ismail, L. C., Lambert, A., Jaffer, Y. A., Bertino, E., Gravett, M. G., Purwar, M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61490-2 · Cited by 870 · see citing works
Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction
Bernstein, I. M., Horbar, J. D., Badger, G. J., Ohlsson, A., & Golan, A. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70513-8 · Cited by 840 · see citing works
Antenatal Betamethasone for Women at Risk for Late Preterm Delivery
Gyamfi-Bannerman, C., Thom, E. A., Blackwell, S. C., Tita, A. T. N., Reddy, U. M., Saade, G. R., Rouse, D. J., McKenna, D. S., Clark, E. A. S., Thorp, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516783 · Cited by 814 · see citing works
Kiserud, T., Piaggio, G. G., Carroli, G., Widmer, M., de Carvalho, J. F., Jensen, L. N., Giordano, D., Cecatti, J. G., Abdel‐Aleem, H., Talegawkar, S. A., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002220 · Cited by 729 · see citing works
ACOG Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002708 · Cited by 711 · see citing works
Committee Opinion No. 700: Methods for estimating the due date
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002046 · Cited by 683 · see citing works
Roberge, S., Nicolaides, K., Demers, S., Hyett, J., Chaillet, N., & Bujold, E. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.09.076 · Cited by 679 · see citing works
Antenatal Corticosteroids for Women at Risk of Late Preterm Delivery
Gyamfi-Bannerman, C., Thom, E., Blackwell, S. C., Tita, A., Reddy, U., Saade, G., Rouse, D., McKenna, D., Clark, E. A. S., Thorp, J. M., et al. (2016) · New England Journal of Medicine · doi:10.1097/01.ogx.0000489576.69844.54 · Cited by 619 · see citing works
Daily oral iron supplementation during pregnancy
Peña‐Rosas, J. P., De‐Regil, L. M., Dowswell, T., & Viteri, F. E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub4 · Cited by 614 · see citing works
Timing of Indicated Late-Preterm and Early-Term Birth
Spong, C. Y., Mercer, B. M., D'Alton, M., Kilpatrick, S., Blackwell, S., & Saade, G. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182255999 · Cited by 581 · see citing works
Daily oral iron supplementation during pregnancy
Peña-Rosas, J. P., De-Regil, L. M., Garcia-Casal, M. N., & Dowswell, T. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004736.pub5 · Cited by 565 · see citing works
Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002237 · Cited by 561 · see citing works
Lees, C., Marlow, N., Arabin, B., Bilardo, C. M., Brezinka, C., Derks, J. B., Duvekot, J., Frusca, T., Diemert, A., Ferrazzi, E., et al. (2013) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.13190 · Cited by 540 · see citing works
Papageorghiou, A. T., Yu, C.-S., Bindra, R., Pandis, G. K., & Nicolaides, K. H. (2001) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.0960-7692.2001.00572.x · Cited by 538 · see citing works
A systematic review of the ultrasound estimation of fetal weight
Dudley, N. J. (2005) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.1751 · Cited by 537 · see citing works
Racial/ethnic standards for fetal growth: the NICHD Fetal Growth Studies
Buck Louis, G. M., Grewal, J., Albert, P. S., Sciscione, A., Wing, D. A., Grobman, W. A., Newman, R. B., Wapner, R., D’Alton, M. E., Skupski, D., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.08.032 · Cited by 532 · see citing works
The cerebroplacental Doppler ratio revisited
Baschat, A., & Gembruch, U. (2003) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.20 · Cited by 505 · see citing works
Monitoring of fetuses with intrauterine growth restriction: a longitudinal study
Hecher, K., Bilardo, C. M., Stigter, R. H., Ville, Y. G., Hackelöer, B.-J., Kok, H. J., Sénat, M., & Visser, G. H. A. (2001) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.0960-7692.2001.00590.x · Cited by 492 · see citing works
Intrauterine growth restriction: new concepts in antenatal surveillance, diagnosis, and management
Figueras, F., & Gardosi, J. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.08.055 · Cited by 485 · see citing works
Predictors of neonatal outcome in early-onset placental dysfunction
Baschat, A. A., Cosmi, E., Bilardo, C. M., Wolf, H., Berg, C., Rigano, S., Germer, U., Moyano, D., Turan, S., Hartung, J., et al. (2007) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000253215.79121.75 · Cited by 485 · see citing works
Tolsa, C. B., Zimine, S., Warfield, S. K., Freschi, M., Rossignol, A. S., Lazeyras, F., Hanquinet, S., Rousseil, M. P., & Hüppi, P. S. (2004) · Pediatric Research · doi:10.1203/01.pdr.0000128983.54614.7e · Cited by 483 · see citing works
Cerebral-Umbilical Doppler Ratio As a Predictor of Adverse Perinatal Outcome
Gramellini, D., FOLLI, M. C., Raboni, S., Vadora, E., & Merialdi, A. (1992) · Obstetrics and Gynecology · doi:10.1097/00006250-199203000-00018 · Cited by 480 · see citing works
Lees, C. C., Marlow, N., van Wassenaer-Leemhuis, A., Arabin, B., Bilardo, C. M., Brezinka, C., Calvert, S., Derks, J. B., Diemert, A., Duvekot, J. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62049-3 · Cited by 479 · see citing works
Unterscheider, J., Daly, S., Geary, M. P., Kennelly, M. M., McAuliffe, F. M., O'Donoghue, K., Hunter, A., Morrison, J. J., Burke, G., Dicker, P., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.02.007 · Cited by 464 · see citing works
Ferrazzi, E. M., Bozzo, M., Rigano, S., Bellotti, M., Morabito, A., Pardi, G., Battaglia, F. C., & Galan, H. L. (2002) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.0960-7692.2002.00627.x · Cited by 452 · see citing works
McCowan, L. M., Figueras, F., & Anderson, N. H. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.004 · Cited by 451 · see citing works
Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery
Karsdorp, V. H. M., van Vugt, J. M. G., van Geijn, H. P., Kostense, P. J., Arduim, D., Montenegro, N., & Todros, T. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90457-x · Cited by 445 · see citing works
Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Alfirević, Ž., Stampalija, T., & Gyte, G. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007529.pub3 · Cited by 440 · see citing works
Baschat, A. A., Gembruch, U., & Harman, C. R. (2001) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.0960-7692.2001.00591.x · Cited by 435 · see citing works
Fetal growth restriction results in remodeled and less efficient hearts in children
Crispi, F., Bijnens, B., Figueras, F., Bartrons, J., Eixarch, E., Le Noble, F., Ahmed, A., & Gratacós, E. (2010) · Circulation · doi:10.1161/circulationaha.110.937995 · Cited by 435 · see citing works
Perinatal outcome and later implications of intrauterine growth restriction
Pallotto, E. K., & Kilbride, H. W. (2006) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200606000-00008 · Cited by 427 · see citing works
Zinc supplementation for improving pregnancy and infant outcome
Ota, E., Mori, R., Middleton, P., Tobe-Gai, R., Mahomed, K., Miyazaki, C., & Bhutta, Z. A. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000230.pub5 · Cited by 371 · see citing works
Crispi, F., Miranda, J., & Gratacós, E. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.012 · Cited by 362 · see citing works
The estimation of fetal weight by computer-assisted analysis
Warsof, S. L., Gohari, P., Berkowitz, R. L., & Hobbins, J. C. (1977) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(77)90058-8 · Cited by 355 · see citing works
Progression of Doppler abnormalities in intrauterine growth restriction
Turan, O. M., Turan, S., Gungor, S., Berg, C., Moyano, D., Gembruch, U., Nicolaides, K. H., Harman, C. R., & Baschat, A. A. (2008) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.5386 · Cited by 353 · see citing works
Leitner, Y., Fattal-Valevski, A., Geva, R., Eshel, R., Toledano-Alhadef, H., Rotstein, M., Bassan, H., Radianu, B., Bitchonsky, O., Jaffa, A. J., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807302605 · Cited by 332 · see citing works
DeVore, G. R. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.05.024 · Cited by 315 · see citing works
Investigation and management of the small for gestational age fetus
Bullough, S., Navaratnam, K., & Sharp, A. (2020) · Obstetrics Gynaecology & Reproductive Medicine · doi:10.1016/j.ogrm.2020.11.002 · Cited by 315 · see citing works
The GRIT Study Group, & article, P. A. L. A. T. E. O. T. (2003) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1046/j.1471-0528.2003.02014.x · Cited by 305 · see citing works
Fetal and umbilical Doppler ultrasound in high-risk pregnancies
Alfirevic, Z., Stampalija, T., & Dowswell, T. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007529.pub4 · Cited by 304 · see citing works
Papageorghiou, A. T., Kennedy, S., Salomon, L. J., Altman, D. G., Ohuma, E. O., Stones, W. R., Gravett, M. G., Barros, F. C., Victora, C. G., Purwar, M., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.011 · Cited by 301 · see citing works
Diagnosis and surveillance of late-onset fetal growth restriction
Figueras, F., Caradeux, J., Crispi, F., Eixarch, E., Peguero, A., & Gratacos, E. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.003 · Cited by 300 · see citing works
Chien, P. F. W., Arnott, N., Gordon, A., Owen, P., & Khan, K. S. (2000) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11690.x · Cited by 283 · see citing works
Intrauterine growth restriction
(2001) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)90000-6 · Cited by 277 · see citing works
Ego, A., Subtil, D., Grange, G., Thiebaugeorges, O., Senat, M.-V., Vayssiere, C., & Zeitlin, J. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.10.816 · Cited by 263 · see citing works
Risk factors for antepartum and intrapartum stillbirth: a population-based study
Getahun, D., Ananth, C. V., & Kinzler, W. L. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.09.017 · Cited by 258 · see citing works
Hershkovitz, R., Kingdom, J. C., Geary, M. P., & Rodeck, C. H. (2000) · Ultrasound in Obstetrics and Gynecology · doi:10.1046/j.1469-0705.2000.00079.x · Cited by 256 · see citing works
Oros, D., Figueras, F., Cruz‐Martinez, R., Meler, E., Munmany, M., & Gratacos, E. (2011) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.7738 · Cited by 256 · see citing works
Vollgraff Heidweiller‐Schreurs, C. A., De Boer, M. A., Heymans, M. W., Schoonmade, L. J., Bossuyt, P. M. M., Mol, B. W. J., De Groot, C. J. M., & Bax, C. J. (2018) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.18809 · Cited by 255 · see citing works
Obstetric Care Consensus No. 6: Periviable Birth
(2017) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002352 · Cited by 252 · see citing works
Severi, F. M., Bocchi, C., Visentin, A., Falco, P., Cobellis, L., Florio, P., Zagonari, S., & Pilu, G. (2002) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.2002.00652.x · Cited by 248 · see citing works
(2002) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1016/s1470-0328(02)02514-4 · Cited by 248 · see citing works
Cruz-Martínez, R., Figueras, F., Hernandez‐Andrade, E. A., Oros, D., & Gratacós, E. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e31820b0884 · Cited by 247 · see citing works
Effect of placental embolization on the umbilical arterial velocity waveform in fetal sheep
Morrow, R. J., Adamson, S. L., Bull, S. B., & Knox Ritchie, J. W. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90783-7 · Cited by 243 · see citing works
Second-trimester uterine artery Doppler screening in unselected populations: a review
Papageorghiou, A. T., Yu, C.-S., Cicero, S., Bower, S. J., & Nicolaides, K. H. (2002) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/jmf.12.2.78.88 · Cited by 243 · see citing works
Meher, S., Duley, L., Hunter, K., & Askie, L. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.10.016 · Cited by 239 · see citing works
Customized growth charts: rationale, validation and clinical benefits
Gardosi, J. O., Francis, A. I., Turner, S., & Williams, M. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.011 · Cited by 238 · see citing works
Kiserud, T., Benachi, A., Hecher, K., Perez, R. G., Carvalho, J., Piaggio, G., & Platt, L. D. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.010 · Cited by 228 · see citing works
Fetal growth restriction: the etiology
MAULIK, D. (2006) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200606000-00006 · Cited by 228 · see citing works
Impact of fetal growth restriction on mortality and morbidity in a very preterm birth cohort
Zeitlin, J., El Ayoubi, M., Jarreau, P.-H., Draper, E. S., Blondel, B., Künzel, W., Cuttini, M., Kaminski, M., Gortner, L., Van Reempts, P., et al. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.05.002 · Cited by 223 · see citing works
Biophysical profile for fetal assessment in high risk pregnancies
Lalor, J. G., Fawole, B., Alfirevic, Z., & Devane, D. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000038.pub2 · Cited by 221 · see citing works
Khoury, J., Henriksen, T., Christophersen, B. O., & Tonstad, S. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.05.016 · Cited by 216 · see citing works
Flood, K., Unterscheider, J., Daly, S., Geary, M. P., Kennelly, M. M., McAuliffe, F. M., O'Donoghue, K., Hunter, A., Morrison, J. J., Burke, G., et al. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.05.008 · Cited by 207 · see citing works
Regev, R. H., Lusky, A., Dolfin, T., Litmanovitz, I., Arnon, S., & Reichman, B. L. (2003) · The Journal of Pediatrics · doi:10.1067/s0022-3476(03)00181-1 · Cited by 206 · see citing works
The risk of intrauterine fetal death in the small-for-gestational-age fetus
Pilliod, R. A., Cheng, Y. W., Snowden, J. M., Doss, A. E., & Caughey, A. B. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.06.039 · Cited by 201 · see citing works
Fetal and umbilical Doppler ultrasound in normal pregnancy
Alfirevic, Z., Stampalija, T., & Medley, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001450.pub4 · Cited by 198 · see citing works
Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11-13 weeks
Karagiannis, G., Akolekar, R., Sarquis, R., Wright, D., & Nicolaides, K. H. (2011) · Fetal Diagnosis and Therapy · doi:10.1159/000321694 · Cited by 195 · see citing works
Bellotti, M., Pennati, G., de Gasperi, C., Bozzo, M., Battaglia, F. C., & Ferrazzi, E. M. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.11.018 · Cited by 194 · see citing works
Non-placental causes of intrauterine growth restriction
Hendrix, N., & Berghella, V. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.02.004 · Cited by 188 · see citing works
Animal models of fetal growth restriction: Considerations for translational medicine
Swanson, A. M., & David, A. L. (2015) · Placenta · doi:10.1016/j.placenta.2015.03.003 · Cited by 183 · see citing works
Savchev, S., Figueras, F., Sanz-Cortes, M., Cruz-Lemini, M., Triunfo, S., Botet, F., & Gratacos, E. (2014) · Fetal Diagnosis and Therapy · doi:10.1159/000355525 · Cited by 182 · see citing works
Anderson, N. H., Sadler, L. C., McKinlay, C. J. D., & McCowan, L. M. E. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.10.931 · Cited by 181 · see citing works
Crispi, F., Figueras, F., Cruz-Lemini, M., Bartrons, J., Bijnens, B., & Gratacos, E. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.05.011 · Cited by 181 · cited 1× · see citing works
“It has been associated with metabolic programming that increases the risk of future development of metabolic syndrome and consequent cardiovascular and endocrine diseases.(11,12) It also can contribute to cardiac remodeling, leading to cardiovascular dysfunction that can persist into childhood and adolescence.”
Diagnosis and management of fetal growth restriction
Bamfo, J. E. A. K., & Odibo, A. O. (2011) · Journal of Pregnancy · doi:10.1155/2011/640715 · Cited by 178 · see citing works
Khalil, A. A., Morales‐Roselló, J., Townsend, R., Morlando, M., Papageorghiou, A. T., Bhide, A., & Thilaganathan, B. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15729 · Cited by 176 · see citing works
Unterscheider, J., O’Donoghue, K., Daly, S., Geary, M. P., Kennelly, M. M., McAuliffe, F. M., Hunter, A., Morrison, J. J., Burke, G., Dicker, P., et al. (2014) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-14-63 · Cited by 172 · see citing works
Groom, K. M., & David, A. L. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.565 · Cited by 170 · see citing works
Baschat, A. A., Gembruch, U., Weiner, C. P., & Harman, C. R. (2003) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.149 · Cited by 166 · see citing works
Savchev, S., Figueras, F., Cruz‐Martinez, R., Illa, M., Botet, F., & Gratacos, E. (2012) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.10150 · Cited by 160 · see citing works
Meher, S., Hernandez‐Andrade, E. A., Basheer, S. N., & Lees, C. C. (2015) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.14818 · Cited by 158 · see citing works
Grantz, K. L., Hediger, M. L., Liu, D., & Buck Louis, G. M. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.593 · Cited by 154 · see citing works
Baschat, A. A., & Weiner, C. P. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70505-9 · Cited by 151 · see citing works
Placental Pathology of Idiopathic Intrauterine Growth Retardation at Term
Salafia, C., Vintzileos, A. M., Silberman, L., Bantham, K., & Vogel, C. (1992) · American Journal of Perinatology · doi:10.1055/s-2007-999316 · Cited by 150 · see citing works
Sultana, Z., Maiti, K., Dedman, L., & Smith, R. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.567 · Cited by 148 · see citing works
Stage-based approach to the management of fetal growth restriction
Figueras, F., & Gratacos, E. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4412 · Cited by 140 · see citing works
Madden, J. V., Flatley, C. J., & Kumar, S. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.02.008 · Cited by 133 · see citing works
Raju, T. N. K., Mercer, B. M., Burchfield, D. J., et al. (2014) · Journal of Perinatology · doi:10.1038/jp.2014.70 · Cited by 130 · see citing works
Yagel, S., Kivilevitch, Z., Cohen, S. M., Valsky, D. V., Messing, B., Shen, O., & Achiron, R. (2010) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.7622 · Cited by 129 · see citing works
Hernandez‐Andrade, E. A., Horacio Figueroa, D., Jansson, T. T., Rangel-Nava, H. A., & Gratacós, E. (2008) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.5377 · Cited by 129 · see citing works
Predictable progressive Doppler deterioration in IUGR: does it really exist?
Unterscheider, J., Daly, S., Geary, M. P., Kennelly, M. M., McAuliffe, F. M., O'Donoghue, K., Hunter, A., Morrison, J. J., Burke, G., Dicker, P., et al. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.08.039 · Cited by 129 · see citing works
Chauhan, S. P., Gupta, L. M., Hendrix, N. W., & Berghella, V. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.11.025 · Cited by 125 · see citing works
Cerebroplacental Doppler Ratio and Adverse Perinatal Outcomes in Intrauterine Growth Restriction
Odibo, A. O., Riddick, C., Paré, E., Stamilio, D. M., & Macones, G. A. (2005) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2005.24.9.1223 · Cited by 124 · see citing works
Middle Cerebral Artery Peak Systolic Velocity
Mari, G., Abuhamad, A., Cosmi, E., et al. (2005) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2005.24.4.425 · Cited by 123 · see citing works
Self-citationCaradeux, J., Martinez-Portilla, R. J., Peguero, A., Sotiriadis, A., & Figueras, F. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.09.043 · Cited by 122 · see citing works
Figueras, F., Eixarch, E., Meler, E., Iraola, A., Figueras, J., Puerto, B., & Gratacos, E. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.02.016 · Cited by 121 · see citing works
Cruz-Martínez, R., Figueras, F., Oros, D., Padilla, N., Meler, E., Hernandez‐Andrade, E. A., & Gratacós, E. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.05.028 · Cited by 121 · see citing works
Medicine of the Fetus and Mother
Plauché, W. C. (1993) · JAMA · doi:10.1001/jama.1993.03500060102042 · Cited by 118 · see citing works
Cruz-Lemini, M., Crispi, F., Valenzuela-Alcaraz, B., Figueras, F., Sitges, M., Bijnens, B., & Gratacós, E. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15767 · Cited by 116 · cited 1× · see citing works
“It also can contribute to cardiac remodeling, leading to cardiovascular dysfunction that can persist into childhood and adolescence.(13,14) In addition, studies have shown an association between FGR and long-term neurologic impairment, with rates of cognitive and learning disabilities as high as 20%e40% by school age.”
Mongelli, M. (1998) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(98)00349-4 · Cited by 116 · see citing works
Caradeux, J., Martinez-Portilla, R. J., Basuki, T. R., Kiserud, T., & Figueras, F. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.566 · Cited by 115 · see citing works
Uterine artery Doppler flow studies in obstetric practice
Sciscione, A. C., & Hayes, E. J. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.03.027 · Cited by 114 · see citing works
Outcomes of Small for Gestational Age Infants Born at <27 Weeks' Gestation
Jesus, L. C. D., Pappas, A., Shankaran, S., Li, L., Das, A., Bell, E. F., Stoll, B. J., Laptook, A. R., Walsh, M. C., Hale, E. C., et al. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.12.097 · Cited by 113 · see citing works
Sonographic Fetal Weight Estimation: Which Model Should Be Used?
Melamed, N., Yogev, Y., Meizner, I., Mashiach, R., Bardin, R., & Ben-Haroush, A. (2009) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2009.28.5.617 · Cited by 112 · see citing works
Early onset fetal growth restriction
Dall’Asta, A., Brunelli, V., Prefumo, F., Frusca, T., & Lees, C. C. (2017) · Maternal Health, Neonatology and Perinatology · doi:10.1186/s40748-016-0041-x · Cited by 110 · see citing works
McCowan, L. M. E., Harding, J. E., Roberts, A. B., Barker, S. E., Ford, C., & Stewart, A. W. (2000) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(00)70494-7 · Cited by 101 · see citing works
Fetal growth velocity and body proportion in the assessment of growth
Hiersch, L., & Melamed, N. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.014 · Cited by 100 · see citing works
Groom, K. M., McCowan, L. M., Mackay, L. K., Lee, A. C., Said, J. M., Kane, S. C., Walker, S. P., van Mens, T. E., Hannan, N. J., Tong, S., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.014 · Cited by 100 · see citing works
Zinc supplementation for improving pregnancy and infant outcome
Mori, R., Ota, E., Middleton, P., Tobe-Gai, R., Mahomed, K., & Bhutta, Z. A. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000230.pub4 · Cited by 100 · see citing works
Schwarze, A., Gembruch, U., Krapp, M., Katalinic, A., Germer, U., & Axt‐Fliedner, R. (2005) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.1914 · Cited by 98 · see citing works
Severe fetal growth restriction at 26-32 weeks: key messages from the TRUFFLE study
Bilardo, C. M., Hecher, K., Visser, G. H. A., Papageorghiou, A. T., Marlow, N., Thilaganathan, B., Van Wassenaer‐Leemhuis, A., Todros, T., Marsal, K., Frusca, T., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.18815 · Cited by 96 · see citing works
Risk of stillbirth after 37 weeks in pregnancies complicated by small-for-gestational-age fetuses
Trudell, A. S., Cahill, A. G., Tuuli, M. G., Macones, G. A., & Odibo, A. O. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.02.030 · Cited by 95 · see citing works
Stampalija, T., Arabin, B., Wolf, H., Bilardo, C. M., Lees, C., Brezinka, C., Derks, J. B., Diemert, A., Duvekot, J. J., Ferrazzi, E., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.01.001 · Cited by 95 · see citing works
Diagnosis of IUGR: traditional biometry
Platz, E., & Newman, R. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2008.02.002 · Cited by 94 · see citing works
Haddad, B., Winer, N., Chitrit, Y., Houfflin-Debarge, V., Chauleur, C., Bages, K., Tsatsaris, V., Benachi, A., Bretelle, F., Gris, J.-C., et al. (2016) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000001673 · Cited by 92 · see citing works
The head-to-abdomen circumference ratio: a reappraisal
David, C., Gabrielli, S., Pilu, G., & Bovicelli, L. (1995) · Ultrasound in Obstetrics & Gynecology · doi:10.1046/j.1469-0705.1995.05040256.x · Cited by 90 · see citing works
Risk Factors and Estimation Tool for Death Among Extremely Premature Infants: A National Study
Bader, D., Kugelman, A., Boyko, V., Levitzki, O., Lerner‐Geva, L., Riskin, A., & Reichman, B. L. (2010) · PEDIATRICS · doi:10.1542/peds.2009-1607 · Cited by 88 · see citing works
Groom, K., McCowan, L., Mackay, L., Lee, A., Gardener, G., Unterscheider, J., Sekar, R., Dickinson, J., Muller, P., Reid, R., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15658 · Cited by 88 · see citing works
BORRELL, A., Grande, M., Pauta, M., et al. (2017) · Fetal Diagnosis and Therapy · doi:10.1159/000479506 · Cited by 85 · see citing works
Keating, S. J., Melamed, N., Walker, M., Sebire, N. J., Levytska, K., Higgins, M., & Kingdom, J. C. (2016) · American Journal of Perinatology · doi:10.1055/s-0036-1592347 · Cited by 85 · see citing works
Arterial and venous Doppler in the diagnosis and management of early onset fetal growth restriction
Baschat, A. A. (2005) · Early Human Development · doi:10.1016/j.earlhumdev.2005.09.008 · Cited by 81 · see citing works
Cortés, M. S., Figueras, F., Bargalló, N., Padilla, N., Amat‐Roldan, I., & Gratacós, E. (2010) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.7724 · Cited by 81 · see citing works
Deter, R. L., Lee, W., Yeo, L., Erez, O., Ramamurthy, U., Naik, M., & Romero, R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.12.210 · Cited by 80 · see citing works
Acid-base characteristics of fetuses with intrauterine growth retardation during labor and delivery
Lin, C.-C., Moawad, A. H., Rosenow, P. J., & River, P. (1980) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(80)90695-x · Cited by 77 · see citing works
Conde‐Agudelo, A., Bird, S., Kennedy, S., Villar, J., & Papageorghiou, A. T. (2014) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.13096 · Cited by 71 · see citing works
Mathematical model for interpretation of Doppler velocity waveform indices
Thompson, R. S., & Stevens, R. J. (1989) · Medical & Biological Engineering & Computing · doi:10.1007/bf02441484 · Cited by 71 · see citing works
Systematic review and meta-analysis of middle cerebral artery Doppler to predict perinatal wellbeing
Morris, R. K., Say, R., Robson, S. C., Kleijnen, J., & Khan, K. S. (2012) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2012.07.027 · Cited by 70 · see citing works
Cruz‐Martinez, R., Savchev, S., Cruz‐Lemini, M., Mendez, A., Gratacos, E., & Figueras, F. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14706 · Cited by 70 · see citing works
Kiserud, T., Piaggio, G. G., Carroli, G., Widmer, M., de Carvalho, J. F., Jensen, L. N., Giordano, D., Cecatti, J. G., Abdel‐Aleem, H., Talegawkar, S. A., et al. (2017) · PLoS Medicine · doi:10.1371/journal.pmed.1002284 · Cited by 70 · see citing works
Poon, L. C., Lesmes, C., Gallo, D. M., Akolekar, R., & Nicolaides, K. H. (2015) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.14904 · Cited by 68 · see citing works
Parry, S., Sciscione, A., Haas, D. M., Grobman, W. A., Iams, J. D., Mercer, B. M., Silver, R. M., Simhan, H. N., Wapner, R. J., Wing, D. A., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.013 · Cited by 66 · see citing works
Bed rest in hospital for suspected impaired fetal growth
Say, L., Gülmezoglu, A. M., & Hofmeyr, G. J. (1996) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000034 · Cited by 64 · see citing works
Egaña‐Ugrinovic, G., Cortés, M. S., Couve‐Pérez, C., Figueras, F., & Gratacós, E. (2014) · Prenatal Diagnosis · doi:10.1002/pd.4381 · Cited by 62 · see citing works
David, C., Tagliavini, G., Pilu, G., Rudenholz, A., & Bovicelli, L. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70347-2 · Cited by 62 · see citing works
Wold, S. H. W., Sommerfelt, K., Reigstad, H. M., Rønnestad, A. E., Medbö, S., Farstad, T., Kaaresen, P. I., Støen, R. Ø., Leversen, K. T., Irgens, L. M., et al. (2009) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2009.157800 · Cited by 61 · see citing works
Genomic Microarray in Fetuses with Early Growth Restriction: A Multicenter Study
BORRELL, A., Grande, M., Meler, E., et al. (2016) · Fetal Diagnosis and Therapy · doi:10.1159/000452217 · Cited by 61 · see citing works
A Practical Guide to Fetal Echocardiography (Normal and Abnormal Hearts)
Kapusta, L. (2011) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2011.02.019 · Cited by 60 · see citing works
Definition and management of fetal growth restriction: a survey of contemporary attitudes
Unterscheider, J., Daly, S., Geary, M. P., Kennelly, M., McAuliffe, F. M., O’Donoghue, K., Hunter, A. J., Morrison, J. J., Burke, G., Dicker, P., et al. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.11.022 · Cited by 60 · see citing works
Story, L., Damodaram, M. S., Allsop, J. M., McGuinness, A. E., Patel, A., Wylezinska, M., Hagberg, H., Kumar, S., & Rutherford, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.032 · Cited by 60 · see citing works
Ganzevoort, W., Mensing Van Charante, N., Thilaganathan, B., Prefumo, F., Arabin, B., Bilardo, C. M., Brezinka, C., Derks, J. B., Diemert, A., Duvekot, J. J., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17433 · Cited by 60 · see citing works
Cortés, M. S., Egaña‐Ugrinovic, G., Zupan, R., Figueras, F., & Gratacós, E. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.12.008 · Cited by 58 · see citing works
The PREM score: a graphical tool for predicting survival in very preterm births
Cole, T. J., Hey, E. N., & Richmond, S. W. J. (2009) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2009.164533 · Cited by 58 · see citing works
Villar, J., Ismail, L. C., Urias, E. S., Giuliani, F., Ohuma, E. O., Victora, C. G., Papageorghiou, A. T., Altman, D. G., Garza, C., Barros, F. C., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.11.564 · Cited by 58 · see citing works
Comparison of placental pathology in preterm, late-preterm, near-term, and term births
Stanek, J. W. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.10.015 · Cited by 56 · see citing works
The Hadlock Method Is Superior to Newer Methods for the Prediction of the Birth Weight Percentile
Blue, N. R., Savabi, M., Beddow, M. E., Katukuri, V. R., Fritts, C. M., Izquierdo, L. A., & Chao, C. R. (2018) · Journal of Ultrasound in Medicine · doi:10.1002/jum.14725 · Cited by 54 · see citing works
Blue, N. R., Beddow, M. E., Savabi, M., Katukuri, V. R., & Chao, C. R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.08.011 · Cited by 54 · see citing works
Hanley, G. E., & Janssen, P. A. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.06.042 · Cited by 52 · see citing works
Regimens of fetal surveillance for impaired fetal growth
Grivell, R. M., Wong, L., & Bhatia, V. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007113.pub2 · Cited by 52 · see citing works
Uterine artery Doppler screening for adverse pregnancy outcome
Papageorghiou, A. T., & Roberts, N. F. (2005) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000191898.84567.04 · Cited by 51 · see citing works
Visser, G. H. A., Bilardo, C. M., Derks, J. B., Ferrazzi, E., Fratelli, N., Frusca, T., Ganzevoort, W., Lees, C. C., Napolitano, R., Todros, T., et al. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17361 · Cited by 51 · see citing works
Roberts, L., Ling, H. Z., Poon, L. C., Nicolaides, K. H., & Kametas, N. A. (2018) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.19067 · Cited by 50 · see citing works
Yamamoto, R., Ishii, K., Shimada, M., Hayashi, S., Hidaka, N., Nakayama, M., & Mitsuda, N. (2013) · Journal of Obstetrics and Gynaecology Research · doi:10.1111/j.1447-0756.2012.02012.x · Cited by 49 · see citing works
Cruz-Martínez, R., Figueras, F., Hernandez‐Andrade, E. A., Puerto, B., & Gratacós, E. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.02.049 · Cited by 49 · see citing works
Symmetrical and asymmetrical growth restriction in preterm-born children
Bocca-Tjeertes, I., Bos, A., Kerstjens, J., de Winter, A., & Reijneveld, S. (2014) · Pediatrics · doi:10.1542/peds.2013-1739 · Cited by 47 · see citing works
Apel‐Sarid, L., Levy, A., Holcberg, G., & Sheiner, E. (2009) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-009-1255-1 · Cited by 47 · see citing works
Parra-Saavedra, M., Crovetto, F., Triunfo, S., Savchev, S., Peguero, A., Nadal, A., Parra, G., Gratacos, E., & Figueras, F. (2014) · Placenta · doi:10.1016/j.placenta.2014.01.010 · Cited by 47 · see citing works
Cerebral blood flow studies in the diagnosis and management of intrauterine growth restriction
Hernandez‐Andrade, E. A., Stampalija, T., & Figueras, F. (2013) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e32835e0e9c · Cited by 47 · see citing works
Biophysical profile in the treatment of intrauterine growth-restricted fetuses who weigh <1000 g
Kaur, S., Picconi, J. L., Chadha, R., Kruger, M., & Mari, G. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.06.074 · Cited by 46 · see citing works
Monier, I., Ancel, P.-Y., Ego, A., Jarreau, P.-H., Lebeaux, C., Kaminski, M., Goffinet, F., & Zeitlin, J. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.02.001 · Cited by 46 · see citing works
Longitudinal quantitation of middle cerebral artery blood flow in normal human fetuses
Veille, J.-C., Hanson, R., & Tatum, K. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90406-9 · Cited by 42 · see citing works
A Practical Guide to Fetal Echocardiography: Normal and Abnormal Hearts
Abuhamad, A., & Chaoui, R. (2009) · Cited by 42 · see citing works
Self-citationYordan, J., Holbrook, B., Nirgudkar, P., Mozurkewich, E., & Blue, N. (2017) · American Journal of Perinatology · doi:10.1055/s-0037-1604059 · Cited by 41 · see citing works
Regimens of fetal surveillance for impaired fetal growth
Grivell, R. M., Wong, L., & Bhatia, V. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007113.pub3 · Cited by 40 · see citing works
A Practical Approach to Fetal Growth Restriction
Copel, J. A., & Bahtiyar, M. O. (2014) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000000232 · Cited by 39 · see citing works
Abuhamad, A., Minton, K. K., Benson, C. B., Chudleigh, T., Crites, L., Doubilet, P. M., Driggers, R., Lee, W., Mann, K. V., Perez, J. J., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.10.016 · Cited by 37 · see citing works
Self-citationShort‐term outcome of periviable small‐for‐gestational‐age babies: is our counseling up to date?
Lawin‐O'Brien, A. R., Dall’Asta, A., Knight, C. L., Sankaran, S., Scala, C., Khalil, A. A., Bhide, A., Heggarty, S., Rakow, A., Pasupathy, D., et al. (2016) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.15973 · Cited by 33 · see citing works
Monier, I., Ego, A., Benachi, A., Ancel, P.-Y., Goffinet, F., & Zeitlin, J. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.08.012 · Cited by 32 · see citing works
Fetal growth restriction at the limits of viability
Visser, G. H. A., Bilardo, C. M., & Lees, C. (2014) · Fetal Diagnosis and Therapy · doi:10.1159/000358058 · Cited by 32 · see citing works
Sagi‐Dain, L., Peleg, A., & Sagi, S. (2017) · Prenatal Diagnosis · doi:10.1002/pd.5160 · Cited by 28 · see citing works
An, G., Lin, Y., Xu, L. P., Huang, H. L., Liu, S. P., Yu, Y. H., & Yang, F. (2018) · Molecular Cytogenetics · doi:10.1186/s13039-018-0382-4 · Cited by 28 · see citing works
Absence of End-Diastolic Flow Velocity in the Umbilical Artery: A Review
Forouzan, I. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199503000-00026 · Cited by 24 · see citing works
Chung, M. H., Shin, C. O., & Lee, J. (2018) · Korean Journal of Pediatrics · doi:10.3345/kjp.2018.61.4.114 · Cited by 24 · see citing works
Maggio, L., Dahlke, J. D., Mendez-Figueroa, H., Albright, C. M., Chauhan, S. P., & Wenstrom, K. D. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000737 · Cited by 23 · see citing works
Survival of pregnancies with small for gestational age detected before 24 weeks gestation
Story, L., Sankaran, S., Mullins, E., Tan, S., Russell, G., Kumar, S., & Kyle, P. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.02.005 · Cited by 20 · see citing works
Trudell, A., Cahill, A. G., Macones, G. A., & Odibo, A. O. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.202 · Cited by 20 · see citing works
Tsuge, M., Hida, A. I., Minematsu, T., Honda, N., Oshiro, Y., Yokoyama, M., & Kondo, Y. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2018.10.003 · Cited by 19 · see citing works
Chauhan, S. P., & Blackwell, S. C. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2013.07.012 · Cited by 16 · see citing works
Doppler Ultrasonography and Fetal Well‐Being
Trudinger, B. (2007) · doi:10.1002/9780470753323.ch28 · Cited by 9 · see citing works
Rosner, J., Rochelson, B., Rosen, L., Roman, A., Vohra, N., & Tam Tam, H. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.806475 · Cited by 7 · see citing works
Blue, N. R., Beddow, M. E., Savabi, M., Katukuri, V. R., & Chao, C. R. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000554435.24315.f0 · Cited by 6 · see citing works
Roberge, S., Nicolaides, K. H., Demers, S., et al. (2017) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000511998.98893.df · Cited by 5
52: Racial/Ethnic differences in fetal growth, the NICHD fetal growth studies
Louis, G. M. B., Grewal, J., Albert, P. S., SCISCIONE, A. C., Nageotte, M. P., Grobman, W. A., Newman, R., Wapner, R. J., D’Alton, M. E., Skupski, D. W., et al. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.10.098 · Cited by 5 · see citing works
Halevy, R. S., Katz, A. A., Regev, R. H., Markovitch, O., Sharony, R., Paz, Y. G., & Biron‐Shental, T. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1391776 · Cited by 4 · see citing works
Genomic Microarray in Fetuses With Early Growth Restriction: A Multicenter Study
BORRELL, A., Grande, M., Meler, E., et al. (2018) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000530435.23065.7c · Cited by 4
Frauenschuh, I., Frambach, T., Karl, S., et al. (2014) · Zeitschrift für Geburtshilfe und Neonatologie · doi:10.1055/s-0034-1384514 · Cited by 3 · see citing works
Parra-Saavedra, M. A., Crovetto, F., Triunfo, S., Savchev, S., Nadal, A., Gratacós, E., & Figueras, F. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.13592 · Cited by 1 · see citing works
Meher, S., Lees, C. C., & Hernandez‐Andrade, E. A. (2014) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.13924
Lees, C. C., Marlow, N., Leemhuis, A. G., Arabin, B., Bilardo, C. M., Brezinka, C., Calvert, S., Derks, J. B., Diemert, A., Duvekot, J. J., et al. (2015) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000471592.76233.5d
Maggio, L., Dahlke, D., Figueroa, H. M., et al. (2016) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000479515.96285.86
Blue, N. R., Perez, J. M., Holbrook, B. D., Nirgudkar, P. A., & Mozurkewich, E. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.11.148
Monier, I., Ego, A., & Zeitlin, J. A. (2019) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2018.08.457
BORRELL, A., Grande, M., Pauta, M., et al. (2017) · Figshare · doi:10.6084/m9.figshare.5387956
Middle Cerebral Artery Peak Systolic Velocity
Mari, G. (2005) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2005.24.5.697
Flagged first, then by citations
Research works printed but not linked: 1
- Frauenschuh, 2014, [Ductus venosus blood flow prior to intrauterine foetal death in severe placental insufficiency can be unaffected as shown by doppler sonography], Z Geburtshilfe Neonatol, 218, 218
Cited by
Sorted by citations
(2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004251 · Cited by 453 · see citing works
The diagnosis and management of suspected fetal growth restriction: an evidence-based approach
LEES, C. C., Romero, R. J., Stampalija, T., Dall’Asta, A., DeVore, G. R., Prefumo, F., Frusca, T., Visser, G. H. A., Hobbins, J. C., Baschat, A., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.11.1357 · Cited by 218 · see citing works
Indications for Outpatient Antenatal Fetal Surveillance
(2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004407 · Cited by 151 · see citing works
Brandt, J. S., & Ananth, C. V. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.06.059 · Cited by 115 · see citing works
Antepartum Fetal Surveillance: ACOG Practice Bulletin, Number 229
(2021) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000004410 · Cited by 106 · see citing works
Hypoxia and Mitochondrial Dysfunction in Pregnancy Complications
Hu, X., & Zhang, L. (2021) · Antioxidants · doi:10.3390/antiox10030405 · Cited by 87 · see citing works
Data-Driven Modeling of Pregnancy-Related Complications
Espinosa, C. A., Becker, M., Marić, I., Wong, R. J., Shaw, G. M., Gaudilliere, B. L., Aghaeepour, N., Stevenson, D. K., Stelzer, I. A., Peterson, L. S., et al. (2021) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2021.01.007 · Cited by 71 · see citing works
Long-term implications of fetal growth restriction
D’Agostin, M., Morgia, C. D. S., Vento, G., & Nobile, S. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i13.2855 · Cited by 73 · see citing works
Roeckner, J. T., Pressman, K., Odibo, L., Duncan, J. R., & Odibo, A. O. (2021) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.23638 · Cited by 60 · see citing works
(2023) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15590 · Cited by 57 · see citing works
“The Society for Maternal-Fetal Medicine (SMFM) recommends abandoning the term intrauterine growth restriction.(3) Other national guidelines defined SGA and FGR differently.”
BackgroundInfluentialShould twin-specific growth charts be used to assess fetal growth in twin pregnancies?
Hiersch, L., Barrett, J. F. R., Fox, N. S., Rebarber, A., Kingdom, J. C., & Melamed, N. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.01.027 · Cited by 61 · see citing works
Short- and Long-Term Implications of Small for Gestational Age
Fung, C. M., & Zinkhan, E. K. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.02.004 · Cited by 52 · see citing works
National and international guidelines on the management of twin pregnancies: a comparative review
Weitzner, O., Barrett, J. F. R., Murphy, K. E., Kingdom, J. C., Aviram, A., Mei‐Dan, E., Hiersch, L., Ryan, G., Mieghem, T. V., Abbasi, N., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.05.022 · Cited by 57 · see citing works
Irani, R. A., Coscia, L. A., Chang, E. B., & Lappen, J. R. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.04.022 · Cited by 58 · see citing works
Sławek-Szmyt, S., Kawka‐Paciorkowska, K., Ciepłucha, A., Lesiak, M., & Ropacka‐Lesiak, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206048 · Cited by 50 · see citing works
The role of the fetal biophysical profile in the management of fetal growth restriction
Baschat, A. A., Galan, H. L., Lee, W., DeVore, G. R., Mari, G., Hobbins, J., Vintzileos, A., Platt, L. D., & Manning, F. A. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.01.020 · Cited by 42 · see citing works
Society for Maternal-Fetal Medicine Consult Series #68: Sickle cell disease in pregnancy
Sinkey, R. G., Ogunsile, F. J., Kanter, J., Bean, C., & Greenberg, M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.10.031 · Cited by 46 · see citing works
Zhang, Y., Zhong, M., & Zheng, D. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16080 · Cited by 40 · see citing works
Mylrea‐Foley, B., Thornton, J., Mullins, E., Marlow, N., Hecher, K., Ammari, C., Arabin, B., Berger, A., Bergman, E., Bhide, A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-055543 · Cited by 38 · see citing works
A systematic review of maternal TORCH serology as a screen for suspected fetal infection
Fitzpatrick, D., Holmes, N. E., & Hui, L. (2021) · Prenatal Diagnosis · doi:10.1002/pd.6073 · Cited by 40 · see citing works
“These results support recent SMFM recommendations against the use of TORCH serology for late onset growth restriction in the absence of specific clinical risk factors for fetal infection.(13) There was consensus amongst the authors of the individual studies that the clinical utility of maternal TORCH serology was low.”
InfluentialPauta, M., Martinez-Portilla, R. J., Meler, E., Otaño, J., & BORRELL, A. (2023) · Prenatal Diagnosis · doi:10.1002/pd.6339 · Cited by 39 · see citing works
LEES, C. C., Stampalija, T., & Hecher, K. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23664 · Cited by 37 · see citing works
Schreiber, V., Hurst, C., da Silva Costa, F., Stoke, R., Turner, J., & Kumar, S. (2023) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.26035 · Cited by 34 · see citing works
Gordijn, S. J., & Ganzevoort, W. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26037 · Cited by 30 · see citing works
Dichorionic twin-specific vs singleton growth references for diagnosis of fetal growth restriction
Shea, S. K., Likins, B., Boan, A. D., Newman, R., & Finneran, M. M. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.03.022 · Cited by 31 · see citing works
Spencer, R. N., Maksym, K., Hecher, K., Maršál, K., Figueras, F., Ambler, G., Whitwell, H. J., Nene, N. R., Sebire, N. J., Hansson, S. R., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci169199 · Cited by 32 · see citing works
Impact of adding abdominal circumference to the definition of fetal growth restriction
Combs, C. A., Castillo, R., Webb, G. W., & Rosario, A. D. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100382 · Cited by 24 · see citing works
Stevens, D. R., Rosen, E. M., Wickle, K. V., McNell, E. E., Bommarito, P. A., Calafat, A. M., Botelho, J. C., Sinkovskaya, E. S., Przybylska, A., Saade, G. R., et al. (2023) · Environmental Research · doi:10.1016/j.envres.2023.115975 · Cited by 32 · see citing works
Self-citationGrantz, K. L., Grewal, J., Kim, S., Grobman, W. A., Newman, R., Owen, J., SCISCIONE, A. C., Skupski, D. W., Chien, E. K., Wing, D. A., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.006 · Cited by 29 · see citing works
Reforma, L. G., Febres-Cordero, D. A., Trochtenberg, A., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.11.1358 · Cited by 28 · see citing works
Fetal growth and gestational age prediction by machine learning
Ananth, C. V., & Brandt, J. S. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30143-6 · Cited by 26 · see citing works
Patterns of Brain Sparing in a Fetal Growth Restriction Cohort
Steller, J. G., Gumina, D. L., Driver, C., Peek, E., Galan, H. L., Reeves, S. A., & Hobbins, J. C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154480 · Cited by 25 · see citing works
Liauw, J., Mayer, C., Albert, A., Fernandez, A., & Hutcheon, J. A. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04324-0 · Cited by 25 · see citing works
Grantz, K. L. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.02.003 · Cited by 27 · see citing works
Evaluation and Management of Suspected Fetal Growth Restriction
Bruin, C. M., Damhuis, S. E., Gordijn, S. J., & Ganzevoort, W. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.02.007 · Cited by 26 · see citing works
Mechanistic insights into the development of severe fetal growth restriction
Gumina, D. L., & Su, E. J. (2023) · Clinical Science · doi:10.1042/cs20220284 · Cited by 23 · see citing works
Bashat, D. B., Thaler, A., Lerman, H., Even‐Sapir, E., Hutchison, M., Evans, K. C., Orr‐Urtreger, A., Cedarbaum, J. M., Droby, A., Giladi, N., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00405-9 · Cited by 23 · see citing works
Pagé, J., Blue, N. R., & Silver, R. M. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.03.001 · Cited by 23 · see citing works
Maternal rest improves growth in small-for-gestational-age fetuses (<10th percentile)
DeVore, G. R., Polanco, B., Lee, W., Fowlkes, J. B., Peek, E., Putra, M., & Hobbins, J. C. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.04.024 · Cited by 22 · see citing works
Oluklu, D., Beşer, D. M., Hendem, D. U., Yıldırım, M., Koç, B. L., Tanaçan, A., & Şahın, D. (2022) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14602 · Cited by 22 · see citing works
Silver, R. M., & Reddy, U. M. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.05.042 · Cited by 22 · see citing works
Mascherpa, M., Pegoire, C., Meroni, A., Minopoli, M., Thilaganathan, B., Frick, A., & Bhide, A. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.27568 · Cited by 21 · see citing works
“Estimated fetal weight (EFW) below the 10 th percentile is referred to as FGR or small for gestational age (SGA) according to the American College of Obstetricians and Gynecologists 4 , a definition adopted by the Society for Maternal–Fetal Medicine (SMFM) 5 .”
MethodFisher, S. A., Miller, E. S., Yee, L. M., Grobman, W. A., & Premkumar, A. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100676 · Cited by 23 · see citing works
Monier, I., Receveur, A., Houfflin‐Debarge, V., Goua, V., Castaigne, V., Jouannic, J., Mousty, E., Saliou, A. ‐., Bouchghoul, H., Rousseau, T., et al. (2021) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.05.035 · Cited by 24 · see citing works
Hong, J., Crawford, K., Cavanagh, E., da Silva Costa, F., & Kumar, S. (2024) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.27513 · Cited by 21 · see citing works
Mitochondrial dysfunction and oxidative stress in selective fetal growth restriction
Hu, Y., Lin, Y., Yang, J., Wang, S., Gao, L., Bi, Y., & Wang, Y. (2024) · Placenta · doi:10.1016/j.placenta.2024.09.005 · Cited by 21 · see citing works
Nüsken, E., Appel, S., Saschin, L., Kuiper-Makris, C., Oberholz, L., Schömig, C., Tauscher, A., Dötsch, J., Kribs, A., Alcazar, M. A. A., et al. (2024) · Cells · doi:10.3390/cells13060501 · Cited by 24 · see citing works
“IUGR, in recent publications mostly referred to as fetal growth restriction (FGR) [10,11], is reliably diagnosed by multiple measurements of fetal size over time only [10].”
BackgroundHong, J. G. S., Crawford, K., Cavanagh, E., Costa, F. D. S., & Kumar, S. (2024) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.17752 · Cited by 19 · see citing works
Shi, D., Zhou, X., Cai, L., Wei, X., Zhang, L., Sun, Q., Zhou, F., & Sun, L. (2023) · The FASEB Journal · doi:10.1096/fj.202300742r · Cited by 19 · see citing works
How and when to recommend delivery of a growth-restricted fetus: A review
Lausman, A. Y., & Kingdom, J. C. (2021) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2021.09.006 · Cited by 20 · see citing works
Odibo, A. O., Kayisli, U. A., Lu, Y., Kayisli, O. G., Schatz, F., Odibo, L., Chen, H., Bronsteen, R. A., & Lockwood, C. J. (2021) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.23760 · Cited by 20 · see citing works
Bommarito, P. A., Stevens, D. R., Welch, B. M., Ospina, M., Calafat, A. M., Meeker, J. D., Cantonwine, D. E., McElrath, T. F., & Ferguson, K. K. (2024) · Environmental Health Perspectives · doi:10.1289/ehp14647 · Cited by 20 · see citing works
Larsen, M. L., Schreiber, V., Krebs, L., Hoei‐Hansen, C. E., & Kumar, S. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100780 · Cited by 18 · see citing works
The Exploration of Fetal Growth Restriction Based on Metabolomics: A Systematic Review
Yao, M., Yang, Z., Rong, X., Hu, X., Yao, N., Zhu, M., Wang, X., Zhu, X., & Yin, J. (2022) · Metabolites · doi:10.3390/metabo12090860 · Cited by 19 · see citing works
Sonographic Assessment of Fetal Growth Abnormalities
Debbink, M. P., Son, S. L., Woodward, P. J., & Kennedy, A. (2020) · Radiographics · doi:10.1148/rg.2021200081 · Cited by 22 · see citing works
Verde, M. L., Savoia, F., Riemma, G., Schiattarella, A., Conte, A. M., Hidar, S., Torella, M., Colacurci, N., FRANCISCIS, P. D., & Morlando, M. (2023) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-06963-4 · Cited by 17 · see citing works
Severity of small-for-gestational-age and morbidity and mortality among very preterm neonates
Minor, K. C., Bianco, K., Sie, L., Druzin, M. L., Lee, H. C., & Leonard, S. A. (2022) · Journal of Perinatology · doi:10.1038/s41372-022-01544-w · Cited by 19 · see citing works
“We used continuous z-scores for analysis, and converted them to percentiles to assign severity based on clinically relevant cutoffs: [28] <3rd, 3rd to <5th, 5th to <10th, and 10 to <15th percentile.”
MethodResultFetal imaging, phenotyping, and genomic testing in modern prenatal diagnosis
Shear, M. A., Robinson, P. N., & Sparks, T. N. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102575 · Cited by 16 · see citing works
Routine third-trimester ultrasound assessment for intrauterine growth restriction
Caradeux, J., Martinez-Portilla, R. J., Martínez, J. M., Ávila, F., & Figueras, F. (2024) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2024.101294 · Cited by 18 · see citing works
Pullins, M. J., Boggess, K., & Porter, T. F. (2023) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005429 · Cited by 18 · see citing works
Rakhanova, Y., Almawi, W. Y., Aimagambetova, G. N., & Riethmacher, D. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05747-7 · Cited by 17 · see citing works
RetractedFantasia, I., Zamagni, G., Lees, C. C., Mylrea‐Foley, B., Monasta, L., Mullins, E., Prefumo, F., & Stampalija, T. (2022) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.14466 · Cited by 16 · see citing works
Powel, J. E., Zantow, E. W., Bialko, M. F., Farley, L. G., Lawlor, M. L., Mullan, S. J., Vricella, L. K., & Tomlinson, T. M. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26044 · Cited by 15 · see citing works
The impact of optimal dating on the assessment of fetal growth
Fries, N., Dhombres, F., Massoud, M., Stirnemann, J., Bessis, R., Haddad, G., & Salomon, L. J. (2021) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-03640-9 · Cited by 16 · see citing works
Mustafa, H. J., Javinani, A., Muralidharan, V., & Khalil, A. A. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101246 · Cited by 17 · see citing works
León-Martínez, D., Lundsberg, L. S., Culhane, J. F., Zhang, J., Son, M., & Reddy, U. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.06.035 · Cited by 16 · see citing works
Calvo, M. U., Infante, X. C. R., Franco, S. R., Pinilla, E. A. I., & Rojas, N. A. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01176-1 · Cited by 15 · see citing works
Umbilical Venous Volume Flow in Late‐Onset Fetal Growth Restriction
Hamidi, O. P., Driver, C., Steller, J. G., Peek, E., Monasta, L., Stampalija, T., Gumina, D. L., DeVore, G. R., Hobbins, J. C., & Galan, H. L. (2022) · Journal of Ultrasound in Medicine · doi:10.1002/jum.15993 · Cited by 14 · see citing works
Recurrence Risk of Fetal Growth Restriction
Blue, N. R., Pagé, J., & Silver, R. M. (2021) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2021.03.002 · Cited by 15 · see citing works
Maternal Age at Menarche Genes Determines Fetal Growth Restriction Risk
Александрович, Р. Е., Churnosova, M., Reshetnikova, Y., Степанов, В. А., Бочарова, А. В., Сереброва, В. Н., Trifonova, E. A., Ponomarenko, I., Николаевна, С. И., Efremova, O. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052647 · Cited by 14 · see citing works
The Hypertensive Disorders of Pregnancy: A Focus on Definitions for Clinical Nephrologists
Longhitano, E., Siligato, R., Torreggiani, M., Attini, R., Masturzo, B., Casula, V., Matarazzo, I., Cabiddu, G., Santoro, D., Versino, E., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123420 · Cited by 17 · see citing works
Potential Prenatal Origins of Necrotizing Enterocolitis
Watson, S. N., & McElroy, S. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.02.006 · Cited by 15 · see citing works
Hong, S., Kang, B. S., Kim, O., Won, S., Kim, H. S., Wie, J., Shin, J., Choi, S., Yun, S.-J., Kim, Y. H., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1351786 · Cited by 12 · see citing works
Czeiger, S., Weissbach, T., Zloto, K., et al. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.01.003 · Cited by 13 · see citing works
Powel, J. E., Chavan, N. R., Zantow, E. W., Bialko, M. F., Farley, L. G., McCormick, K. M., & Tomlinson, T. M. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.04.037 · Cited by 13 · see citing works
Wu, X., He, S., Li, Y., Guo, D., Chen, X., Liang, B., Wang, M., Huang, H., & Xu, L. (2023) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-023-05394-y · Cited by 13 · see citing works
Dall’Asta, A., Stampalija, T., Mecacci, F., Zegarra, R. R., Sorrentino, S., Minopoli, M., Ottaviani, C., Fantasia, I., Barbieri, M., Lisi, F., et al. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.24961 · Cited by 14 · see citing works
Zhou, H., Cheng, K., Li, Y., Fu, F., Li, R., Zhang, Y., Yang, X., Jing, X., Li, F., Han, J., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.856522 · Cited by 16 · see citing works
Ali, S., Kabajaasi, O., Kawooya, M. G., Byamugisha, J. K., Zakus, D., Papageorghiou, A. T., Klipstein‐Grobusch, K., & Rijken, M. J. (2021) · Reproductive Health · doi:10.1186/s12978-021-01233-5 · Cited by 13 · see citing works
Practice Modification for Pandemics
Duzyj, C. M., Thornburg, L. L., & Han, C. S. (2020) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004004 · Cited by 12 · see citing works
Comparing population-based fetal growth standards in a US cohort
Gleason, J. L., Reddy, U. M., Chen, Z., Grobman, W. A., Wapner, R. J., Steller, J. G., Simhan, H. N., Scifres, C., Blue, N. R., Parry, S. I., et al. (2023) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2023.12.034 · Cited by 11 · see citing works
Gao, L., Yang, P., Luo, C., et al. (2023) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1301376 · Cited by 12 · see citing works
Do differences in diagnostic criteria for late fetal growth restriction matter?
Mylrea‐Foley, B., Napolitano, R., Gordijn, S. J., Wolf, H., Lees, C. C., Stampalija, T., Arabin, B., Berger, A., Bergman, E., Bhide, A., et al. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.101117 · Cited by 12 · see citing works
Springer, S., Worda, K., Franz, M., Karner, E., Krampl‐Bettelheim, E., & Worda, C. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12072502 · Cited by 15 · see citing works
Fung, C. M. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1092357 · Cited by 12 · see citing works
Management of late‐onset fetal growth restriction: pragmatic approach
Peasley, R., Abrego, L., Casagrandi, D., Donadono, V., Willinger, M., Conti, G., Seminara, Y., Marlow, N., David, A. L., Attilakos, G., et al. (2023) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.26190 · Cited by 15 · see citing works
“International guidelines differ in their recommended timing of delivery for FGR fetuses 1,2,8,9,45,46 .”
BackgroundErez, O., Gotsch, F., Jung, E., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.11.1276 · Cited by 12 · see citing works
Bligard, K. H., Xu, X., Raghuraman, N., Dicke, J. M., Odibo, A. O., & Frolova, A. I. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2022.06.005 · Cited by 12 · see citing works
Referral scan for congenital anomalies: time to agree on indications
Robertis, V. D., Calì, G., Corbella, P., Formigoni, C., Iuculano, A., Nonino, F., Pasquini, L., Prefumo, F., Sciarrone, A., Stampalija, T., et al. (2022) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.24950 · Cited by 12 · see citing works
González, A., Peguero, A., Meler, E., et al. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.10.055 · Cited by 12 · see citing works
Gatta, A. N. D., Aceti, A., Spinedi, S. F., Martini, S., Corvaglia, L., Sansavini, A., Zuccarini, M., Lenzi, J., Seidenari, A., Dionisi, C., et al. (2023) · European Journal of Pediatrics · doi:10.1007/s00431-023-05104-y · Cited by 11 · see citing works
The Update of Fetal Growth Restriction Associated with Biomarkers
Sun, L. (2022) · Maternal-Fetal Medicine · doi:10.1097/fm9.0000000000000156 · Cited by 12 · see citing works
“ISUOG, SMFM, and FIGO published the guidelines for the diagnosis and management of FGR.(3,8,9) Three out of six guidelines recommend that PAPP-A could be the major first-trimester biomarker for SGA.”
MethodFetal Growth Restriction Before and After Birth.
Westby, A., & Miller, L. (2021) · PubMed · Cited by 13 · see citing works
The association between persistent maternal hypotension and small for gestational age neonates
Reyes, S. D. L., Plunkett, B. A., & Dude, A. (2021) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2021.100449 · Cited by 11 · see citing works
The Application of Hypnosis in Obstetrics
Babbar, S., & Oyarzabal, A. J. (2021) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000635 · Cited by 11 · see citing works
Diagnostic accuracy of fetal growth charts for placenta-related fetal growth restriction
Melamed, N., Hiersch, L., Aviram, A., Mei‐Dan, E., Keating, S. J., & Kingdom, J. C. (2021) · Placenta · doi:10.1016/j.placenta.2021.01.022 · Cited by 11 · see citing works
Sappia, M. S., de Korte, C. L., van Ginneken, B., Ninalga, D., Kondo, S., Kasai, S., Hirasawa, K., Akumu, T., Martín-Isla, C., Lekadir, K., et al. (2025) · Medical Image Analysis · doi:10.1016/j.media.2025.103640 · Cited by 10 · see citing works
Zimmerman, R. M., Hernandez, E. J., Yandell, M. D., Tristani‐Firouzi, M., Silver, R. M., Grobman, W. A., Haas, D. M., Saade, G. A., Steller, J. G., & Blue, N. R. (2025) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-024-07095-6 · Cited by 12 · see citing works
Daggett, E. E., & Ananth, C. V. (2024) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000914 · Cited by 12 · see citing works
Simula, N. K., McRae, K., Habte, R., Fayek, B., Won, E., Liu, Y. D., Albert, A., AbdelHafez, F. F., Terry, J., & Bedaiwy, M. A. (2024) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2024.104285 · Cited by 10 · see citing works
- Authors
- Martins, J. G., Biggio, J. R., & Abuhamad, A.
- Affiliations
- Society for Maternal-Fetal Medicine (US)
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 223
- Issue
- 4
- Pages
- B2-B17
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W3025237121
- Cited by
- 549
- References
- 194
- Citations by year
- 2026: 105 · 2025: 103 · 2024: 91 · 2023: 98 · 2022: 75 · 2021: 61 · 2020: 8
- FWCI
- 22.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Obstetrics and Gynecology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Screening and Diagnostics
- Keywords
- fetal growth restriction, prenatal diagnosis, low molecular weight heparin, sildenafil, activity limitation, chromosomal microarray analysis, prenatal diagnostic testing, umbilical artery Doppler
- MeSH terms
- Adrenal Cortex Hormones, Cesarean Section, Chromosome Aberrations, Female, Fetal Growth Retardation, Gestational Age, Hospitalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review